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Summary 
With the increasing amount of genomic data available, it became obvious that complete 
genome sequences are not sufficient to elucidate a clear biological function. Proteomics 
focuses on the gene products (proteins) and their posttranslational modifications (PTMs) in an 
unbiased and global fashion. Proteomics has become an indispensable tool in the study of 
molecular and cellular biology, and is becoming increasingly important for systems biology 
approaches. It highly profits from the development and improvements in technology, especially 
in mass spectrometry and liquid chromatography. Modern mass spectrometry-based 
approaches are capable of routinely identifying and quantifying thousands of proteins and post-
translational modifications in a single biological experiment.  
 
The aim of this thesis was to develop and optimize quantitative mass spectrometry-based 
approaches to study protein phosphorylation dynamics, and apply them to study the cell cycle 
of fission yeast. To this end, I improved a (phospho)proteomic workflow based on in-solution 
proteome digestion, phosphopeptide enrichment and the use of strong cation exchange and 
TiO2 chromatographies. I replaced the commonly used additive 2,5-dihydroxybenzoic acid 
(DHB) with high concentration of trifluoroacetic acid (TFA), thereby increasing the specificity 
of the phosphopeptide enrichment while reducing contamination of the mass spectrometer. 
With this approach it became possible to identify thousands of phosphorylation events with 
relatively low starting material (1 - 2 mg). 
 
Proteomics can be applied to study complex biological processes such as the cell cycle. The 
cell cycle involves a complex series of highly regulated and evolutionary conserved events. 
Aberrations in the cell cycle have severe implications and can cause cancerous growth; 
therefore, a detailed understanding of the cell cycle and its regulation may identify additional 
targets for cancer therapy. In this work, I used the model organism Schizosaccharomyces 
pombe, also known as fission yeast, to characterize proteome and phosphoproteome 
dynamics in the main phases of the cell cycle. S. pombe is an extensively exploited model 
organism used to study cell cycle control, heterochromatin and differentiation. Here I used 
shot-gun proteomics in combination with a stable isotope labeling by amino acids in cell culture 
(SILAC) method, termed super-SILAC, and intensity-based absolute quantification (iBAQ). 
Combining these methods I was able to measure relative and absolute dynamics of the 
proteome and phosphoproteome during the four main phases of the cell cycle of fission yeast 
(G1, S, G2 and M). Using highly synchronized cells provided by Silke Hauf´s laboratory, I 
estimated copy numbers for 3,178 S. pombe proteins and 3,682 phosphorylation events and 
relatively quantified 65 % of the data across all phases. This data was combined with 
calculated phosphorylation site stoichiometry to estimate the total amount of protein-bound 
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phosphate and its dynamics across the cell cycle. Quantitative changes during the cell cycle 
were infrequent and weak at the proteome level, but prominent at the phosphoproteome level. 
Protein phosphorylation peaked in mitosis, where the median phosphorylation site occupancy 
was 44%, about two-fold higher than in other phases. Using the iBAQ approach, I measured 
copy numbers of 3,178 proteins and combined this information with phosphorylation site 
stoichiometry to estimate the absolute amount of protein-bound phosphate, as well as its 
change across the cell cycle. The results indicated that 23% of the average intracellular ATP 
is utilized by protein kinases to phosphorylate their substrates in order to drive regulatory 
processes during cell division. Accordingly, I observed that phosphate transporters and 
phosphate-metabolizing enzymes are phosphorylated and therefore likely to be regulated in 
mitosis. This is one of the first studies to describe global phosphorylation site stoichiometry 
and the first study to combine this information with absolute protein copy number to calculate 
ATP dynamics during the cell cycle. This will be a valuable resource for systems biologists and 
we hope it will encourage researchers to expand this approach to other modifications to help 
better understand PTM dynamics. 
 
Finally, in collaboration with Ian Hagan´s lab we observed that labeling fission yeast with a 
frequently used version of arginine (13C615N4-arginine) lead to severe mislabeling of multiple 
amino acids and severely compromises the identification of heavy-labeled peptides and 
therefore of proteins. This inability to use 13C615N4-arginine in triple-SILAC experiments limits 
the exploitation of SILAC technology in fission yeast. Through experiments using different 
combinations of SILAC labels we reasoned that the guanidinium group of 13C615N4-arginine is 
catabolized to 15N1-ammonia that is used as a precursor for general amino acid biosynthesis. 
As a consequence, 15N is randomly incorporated in newly synthetized amino acids and at a 
later point in newly synthetized proteins. In order to prevent this arginine conversion, we 
optimized the fission yeast strain previously used for SILAC experiments and growth 
conditions. We show that disruption of Ni2+-dependent urease activity, through deletion of the 
sole Ni2+ transporter Nic1 in combination with ammonium-supplemented medium, blocks this 
re-cycling to enable 13C615N4-arginine labeling for SILAC strategies in S. pombe. The ability to 
routinely perform triple-SILAC experiments with doubly- labelled samples (i.e. Arg and Lys) will 
increase proteome coverage and increase experimental options to understand core principles 
of molecular cell biology. Finally, our study will point the way towards solving of arginine-related 
labeling problems in SILAC experiments in other species. 
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Zusammenfassung 
Mit der zunehmenden Verfügbarkeit von Genomdaten wurde deutlich, dass die vollständigen 
Genomsequenzen nicht ausreichend sind, um eine eindeutige biologische Funktion 
aufzuklären. Proteomik ist eine unvoreingenommene und umfassende Methode, die sich mit 
Genprodukten (Proteine) und deren posttranslationalen Modifikationen (PTM) beschäftigt. Sie 
hat sich als ein unverzichtbares Werkzeug in molekularen und zellbiologischen Studien 
etabliert und wird immer wichtiger für die Systembiologie. Proteomik profitiert stark vom 
technologischen Fortschritt, vor allem in der Massenspektrometrie und der 
Flüssigkeitschromatographie. Mit Hilfe moderner, auf der Massenspektrometrie basierender 
Versuche, ist man in der Lage, routinemäßig tausende von Proteinen und posttranslationale 
Modifikationen in einem biologischen Experiment zu identifizieren und zu quantifizieren.  
 
Ziel dieser Doktorarbeit war die Entwicklung und Optimierung quantitativer 
Massenspektrometrie-basierter Ansätze zur Untersuchung der Phosphorylierungsdynamik 
von Proteinen und diese anschließend zur Analyse des Zellzyklus der Spalthefe anzuwenden. 
Zu diesem Zweck verbesserte ich einen Phosphoproteom-Workflow, basierend auf einem 
Proteinverdau in Lösung, Phosphopeptidanreicherung und der Verwendung von 
Ionenaustausch- und TiO2-Chromatographien. Ich ersetzte die üblicherweise verwendete 2,5-
Dihydroxybenzoesäure (DHB) gegen eine hohe Konzentration an Trifluoressigsäure (TFA), 
wodurch die Spezifität der Phosphopeptidanreicherung erhöht und gleichzeitig die 
Kontamination des Massenspektrometers reduziert wurde. Mit diesem Ansatz ist es möglich, 
tausende von Phosphorylierungsstellen von Proteinen mit relativ niedrigem Ausgangsmaterial 
zu identifizieren (1 - 2 mg). 
 
Proteomik kann angewendet werden, um komplexe biologische Prozesse wie den Zellzyklus 
zu untersuchen. Der Zellzyklus umfasst eine komplexe Reihe von hochregulierten und 
evolutionär konservierten Vorgängen. Aberrationen im Zellzyklus haben schwere 
Auswirkungen und können Krebswachstum verursachen. Daher kann ein genaues 
Verständnis des Zellzyklus und seiner Regulation zur Identifizierung weiterer Targets in der 
Krebstherapie führen. In dieser Arbeit habe ich den Modellorganismus Schizosaccharomyces 
pombe benutzt, der auch als Spalthefe bekannt ist, um die Dynamik des Proteoms und des 
Phosphoproteoms in den wichtigsten Phasen des Zellzyklus zu charakterisieren. S. pombe ist 
ein etablierter Modellorganismus, der verwendet wird, um unter anderem Zellzykluskontrolle, 
Heterochromatin und Differenzierung zu studieren. Hier habe ich Massenspektrometrie-
basierte Proteomikmethoden in Kombination mit stabiler Isotopenmarkierung von 
Aminosäuren in Zellkultur (SILAC), genannt Super-SILAC, und intensitätsbasierter absoluter 
Quantifizierung (iBAQ) verwendet. Durch Kombination dieser Methoden konnte ich die relative 
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und absolute Dynamik des Proteoms und Phosphoproteoms während der vier Hauptphasen 
des Zellzyklus der Spalthefe (G1, S, G2 und M) charakterisieren. An den von Silke Hauf´s 
Labor zur Verfügung gestellten hoch synchronisierten Zellen berechnete ich die Kopiezahlen 
für 3.178 S. pombe Proteine und 3.682 Phosphorylierungsereignisse und 65% der Daten 
konnten über alle Phasen relativ quantifiziert werden. Diese Daten wurden mit der 
Stöchiometrieberechnung von Phosphorylierungsstellen kombiniert, um die Gesamtmenge an 
proteingebundenem Phosphat und seine Dynamik über den Zellzyklus zu bestimmen. 
Quantitative Veränderungen während des Zellzyklus waren auf Proteomebene selten und 
schwach, aber deutlich auf Phosphoproteomebene. Der Level an Proteinphosphorylierung 
erreichte in der Mitose seinen Höhepunkt, wo der Median der besetzten 
Phosphorylierungsstellen bei 44% lag, etwa zweifach höher als in anderen Phasen. Mit dem 
iBAQ Ansatz maß ich Kopiezahlen von 3.178 Proteinen und kombinierte diese Informationen 
mit jenen aus der Stöchiometrieberechnung der Phosphorylierungsstellen, um die absolute 
Menge an proteingebundenem Phosphat, sowie dessen Veränderung über den Zellzyklus 
bestimmen zu können. Die Ergebnisse zeigten, dass 23% des durchschnittlichen 
intrazellulären ATPs durch Proteinkinasen genutzt wird, um ihre Substrate für regulatorische 
Prozesse während der Zellteilung zu phosphorylieren. In Übereinstimmung habe ich 
festgestellt, dass Phosphat-Transporter und phosphatmetabolisierende Enzyme 
phosphoryliert und daher wahrscheinlich in der Mitose reguliert werden. Dies ist eine der ersten 
Studien über die globale Stöchiometrie von Phosphorylierungsstellen und die erste Studie, die 
diese Informationen mit der absoluten Kopiezahl von Proteinen kombiniert, um die ATP-
Dynamik während des Zellzyklus zu berechnen. Sie wird eine wertvolle Quelle für 
Systembiologen sein, und wir hoffen, dass sie Forscher dazu ermutigt, diesen Ansatz auf 
andere Modifikationen zu erweitern, um die PTM Dynamik besser zu verstehen. 
 
Abschließend wurde in Zusammenarbeit mit Iain Hagan´s Labor beobachtet, dass es bei der 
Markierung der Spalthefe mit der häufig verwendeten Version von „schwerem“ Arginin 
(13C615N4-Arginin) zur schwerwiegenden Falschmarkierung zahlreicher Aminosäuren kommt, 
was die Identifizierung von markierten Peptiden und zugehörigen Proteinen erheblich 
beeinträchtigt. Die Tatsache, dass 13C615N4-Arginin nicht in Triple-SILAC Experimenten benutzt 
werden kann, stellt eine erhebliche Einschränkung der SILAC-Technologie in Experimenten in 
der Spalthefe dar. Durch Versuche mit verschiedenen SILAC-Aminosäuren fanden wir heraus, 
dass die Guanidinium-Gruppe von 13C615N4-Arginin in 15N1-Ammoniak katabolisiert wird, 
welches weiter als Vorläufer für die allgemeine Aminosäure-Biosynthese dient. Als Folge wird 
15N zufällig in neu synthetisierte Aminosäuren und zu einem späteren Zeitpunkt in neu 
synthetisierte Proteine eingebaut. Um diese Arginin-Umwandlung zu verhindern, optimierten 
wir den zuvor für SILAC Experimente benutzten Stamm der Spalthefe. Ich konnte zeigen, dass 
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die Unterbrechung der Ni2+-abhängigen Urease-Aktivität durch den Knockout des einzigen 
Ni2+-Transporters Nic1 in Verbindung mit einem durch Ammonium ergänzten Medium, die 
Katabolisierung verhindert und somit eine 13C615N4-Arginin-Markierung für SILAC Experimente 
in S. pombe ermöglicht. Die Fähigkeit, Triple-SILAC Experimente routinemäßig mit zweifach-
markierten Proben (d.h. Arg und Lys) einzusetzen, wird die Tiefe der Proteom Abdeckung 
erhöhen und erweitert somit die experimentellen Möglichkeiten, grundlegende Prinzipien der 
molekularen Zellbiologie besser zu verstehen. Die Ergebnisse dieser Studie können auf 
andere Spezies übertragen werden, um Arginin-bezogene Markierungsprobleme in SILAC 
Experimenten zu beseitigen. 
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1. Introduction 
1.1 Mass-Spectrometry based proteomics  
The central dogma of biology is defined as follows: “…the coded genetic information hard-
wired into DNA is transcribed into individual transportable cassettes, composed of messenger 
RNA (mRNA); each mRNA cassette contains the program for synthesis of a particular protein” 
(1). Currently we realize that there are many exceptions to this rule and that many of the DNA 
regions that were supposed to be non-coding (introns) indeed encode various types of 
functional RNAs (2). With the introduction of shotgun sequencing (3, 4) and next-generation 
sequencing (5) large amounts of DNA sequences are being accumulated. With this data 
available, researchers started to notice that having complete genome sequences is not 
sufficient to elucidate biological function (6), therefore attention shifted towards complementary 
techniques like proteomics, the global study of proteins (7). With the introduction of the first 
integrative and comparative studies, it also became clear that the existence of an open reading 
frame (ORF) in genomic data does not necessarily imply the existence of a expressed gene. 
Furthermore, despite great efforts in bioinformatics, a complicated task remains to accurately 
predict genes from genomic data (8). Therefore, verification of a gene product by proteomic 
methods is an important first step in genome annotation. The link between genomics and 
proteomics is called transcriptomics which is the global profiling of gene expression at the 
mRNA level. Transcriptomics is a very useful tool to identify clusters of genes for which the 
expression is specific for a determined state. These methods are very sensitive but have 
drawbacks due to correlation inconsistencies with mRNA vs detected protein levels (8). 
Proteomics is complementary to both transcriptomics and genomics because it focuses on the 
gene products (proteins) that are the present in the cells and their respective posttranslational 
modifications (PTMs). Furthermore, modifications of the proteins that are not apparent from 
the DNA sequence, such as co- and post-translational modifications, can be determined only 
by proteomic methodologies.  
 
The first approaches used in proteomics were based on two-dimensional (2D) gel 
electrophoresis. In this approach, proteins separated based on isoelectric point and molecular 
weight generate different patterns that could be used to study different perturbations in the cell 
or tissue of interest. The spots (proteins) forming the patterns can be identified using mass 
spectrometry (MS). This method, although widely used in proteomics, has severe 
disadvantages; it is wet-lab intensive and time consuming, it is not able to identify very small 
proteins or proteins with extreme pIs, and it has a limited analytical capacity, i.e. it is generally 
of low throughput in terms of protein identifications. 
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Relatively recent developments made in MS instrumentation, liquid chromatography (LC) and 
bioinformatics approaches resulted in the development of a MS-based technique known as 
“shotgun” or bottom-up proteomics. The goal of this approach is to identify proteins in a 
complex mixture using a combination of LC-MS. This widely used approach involves digestion 
of a whole cell lysate with a protease resulting in peptides that are separated by liquid 
chromatography before being measured with tandem mass spectrometry and analyzed using 
downstream bioinformatic workflows.  
 
 
Figure 1.  Mass Spectrometry based proteomics workflow. In a typical MS experiment cells are lysed. 
Protein samples are digested using a protease. After digestion, peptides are fractionated or 
alternatively enriched for PTMs before being measured using LC-MS. The mass of a peptide is 
recorede in a full scan (MS) and isolated for fragmentation (MS/MS). The information from the MS 
and MS/MS is used to identify peptides and therefore proteins. The samples are quantified and the 
information used to build networks. Adapted from (9). 
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Workflow 
A typical MS-based proteomics experiment (Figure 1) consists of several steps. Initially (step 
1), proteins are extracted from the cells (cell culture or tissue), generating very complex protein 
mixtures. Since the MS of whole proteins is less sensitive and does not provide enough 
information for identification, in step 2 proteins are digested with a protease. Trypsin is the 
most widely used protease, since it is highly efficient, specific and generates peptides with a 
suitable size for MS (better “flyability”). To reduce the complexity of this mixture, peptides are 
fractionated in step 3. Alternatively, for peptide PTM enrichment, affinity resins or modification 
specific antibodies can be used to target specific PTMs. In step 4 peptides are separated using 
high pressure liquid chromatography (HPLC or LC) coupled to a MS through electrospray 
ionization (ESI). In this step, peptides are usually separated using reversed phase 
chromatography, eluting peptides become ionized and enter the instrument as protonated 
peptides. In step 5, after entering the instrument a MS spectrum of peptides eluting at this point 
is recorded in a full scan (mass of the peptide). The most abundant ions (peptides) are then 
selected for fragmentation with tandem MS or MS/MS (step 6). The combination of precursor 
m/z (MS) and its fragment ions (MS/MS) is then matched to known peptide sequences from 
large protein databases using search algorithms in step 7. This results in peptides identified 
that are matched to proteins. Finally (step 8), data are quantified (relatively or absolutely), and 
several experimental conditions are compared directly. All this information is then gathered in 
step 9 and used to build networks of perturbations to the system. 
 
1.2 Mass spectrometry  
Proteomics relies heavily on modern analytical instrumentation. One of the most powerful tools 
for proteomic scientists are mass spectrometers. All mass spectrometers are based on three 
essential components: ion source, mass analyzer and detector (Figure 2). Molecules from the 
sample first need to be ionized in a vacuum since the measurements are made in the gas 
phase (ion source). Ions are then introduced into a mass analyzer, where they are separated 
based on their mass-to-charge ratio (m/z) in an electric and/or magnetic field, before being 
recorded in a detector. The m/z can be used to deduce the mass of the analyte (protein, peptide 
or peptide fragment) with very high precision. There are several types of ion sources, mass 
analyzers and detectors. The type of ionization method used is determined by the analyte, but 
the correct combination of the mass analyzer and detector are the key for the quality and 
reliability of the analysis. The following section will give a brief introduction into the several 
components of a mass spectrometer as well as shortly discuss the different types of 
components available relevant to biological applications. Finally, the type of mass 
spectrometer used in this study will be introduced.  
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Ion source 
Currently MS is the method of choice for the analysis of complex protein samples, but for many 
years it could not be used for the study of biomolecules such as proteins, peptides and nucleic 
acids due to the lack of proper ionization methods. This was first made possible by the 
discovery and introduction of two “soft” ionization methods in 1988, which were recognized in 
2002 with the Nobel Prize in chemistry to John Fenn, Koichi Tanaka and Kurt Wüthrich (Figure 
3). 
 
In the first method termed Matrix-Assisted Laser Desorption/Ionization (MALDI), macro-
molecules are mixed with a light absorbing matrix, crystallized, ionized with a short pulse of 
laser and then desorbed into the vacuum system (10). This method is usually preferred to 
analyze relatively simple peptide and protein mixtures. In the second method, electrospray 
ionization or ESI, macromolecules are transferred from solution into the gas phase. In order to 
do this, the solution containing the analyte is passed through a needle to which a high voltage 
is applied. The solution is dispersed into a fine spray of charged droplets, these droplets are 
evaporated and the charge density increases until the Rayleigh limit is reached and a 
“Coulomb explosion” occurs, reaping the droplets apart. This process is repeated until the 
surface charge density is strong enough to desorb ions from the droplet into the ambient gas.  
 
 
Figure 2.  Basic components of a mass spectrometer. Molecules from the sample first need to be ionized 
in a vacuum since the measurements are made in the gas phase (ion source), then ions are 
introduced into an electric and/or magnetic field (mass analyzer) where ions are separated based 
on their mass-to-charge ratio (m/z), before being detected (detector). The data is recorded in an 
acquisition unit. 
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Protons added during this process give additional charge to the macromolecule (11). ESI can 
be easily coupled to liquid chromatography and is preferred when analyzing complex peptide 
samples.  
Mass analyzer 
Many different types of mass analyzers exist and are based on different principles. These 
include: quadrupole, magnetic sector, ion trap, time-of-flight (TOF), or Fourier transform (FT). 
These mass analyzers can also be combined to analyze both analytes and their fragments 
(MS/MS or MS2). Commonly used mass analyzer combinations (hybrid mass spectrometers) 
are triple quadrupole, quadrupole/TOF and ion trap/Orbitrap. Analyzers like the ion traps can 
perform several MS/MS analysis, also called MSn. Several intrinsic characteristics such as 
resolution, accuracy, sensitivity and dynamic range can vary, depending on the type of mass 
analyzer that is used. Each mass spectrometer has a set of parameters that define its 
performance; here I will briefly introduce them: 
 
Mass Resolution is the ability to distinguish between two points with slightly different mass. 
Resolution is unit-less and depends on the m/z at which it is defined. For example, an 
instrument with a resolution of 240,000 @ 400 m/z can distinguish between two peaks with a 
mass difference of 0.0016 m/z or higher. An instrument with a resolution of 240,000 @ 600 
m/z can “only” distinguish between two peaks with a mass difference of 0.0025 m/z or higher.  
Mass Accuracy is the average deviation of the measured m/z to the real m/z and is usually 
reported in relative units (ppm or parts-per-million). Mass accuracy in ppm is mass dependent. 
Sensitivity is the lowest amount of analyte that provides an MS response (signal).  
Dynamic range of detection is the ratio between the lowest and largest amounts of analyte 
that can be measured simultaneously in a single MS spectrum or in the whole experiment. 
 
Figure 3.  Biomolecule ionization methods. On the left the electrospray ionization and ion introduction 
method is depicted, on the right matrix-assited laser desorption/ionization.  
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Scan rate is the analysis speed or frequency of performing MS or MSn scanning under defined 
conditions.  
 
With the increasing use of MS in biology, the complexity of samples increased, making the use 
of an instrument with high speed, high resolution and high accuracy indispensable. An 
overview of the different type of MS analyzers and combinations of these used in proteomics 
is presented in Table 1. In this study an instrument consisting of a combination of linear ion 
trap/Orbitrap was used. These two types of mass analyzers are described in the next sections.  
 
Table 1. Overview of MS used in proteomics. Table adapted from (12). 
Instrument Applications Resolution 
Mass 
accuracy 
Sensitivity 
Dynamic 
range 
Scan rate 
LIT (LTQ) 
Bottom-up protein identification in high-
complexity, high-throughput analysis, LC-
MSn capabilities 
2,000 100 ppm Femtomole 1e4 Fast 
TQ (TSQ) 
Bottom-up peptide and protein quantification; 
medium complexity samples, peptide and 
protein quantification (SRM, MRM, precursor, 
product, neutral fragment monitoring) 
2,000 100 ppm Attomole 1e6 Moderate 
LTQ-Orbitrap 
Protein identification, quantification, PTM 
identification 
240,000 2 ppm Femtomole 1e4 Moderate 
LTQ-TICR, 
Q-FTICR 
Protein identification, quantification, PTM 
identification, top-down protein identification 
>500,000 <2 ppm Femtomole 1e4 Slow, slow 
Q-TOF, 
IT-TOF 
Bottom-up, top-down protein identification, 
PTM identification 
10,000 2–5 ppm Attomole 1e6 Moderate, fast 
Q-LIT 
Bottom-up peptide and protein quantification; 
medium complexity samples, peptide and 
protein quantification (SRM, MRM, precursor, 
product, neutral fragment monitoring) 
2,000 100 ppm Attomole 1e6 Moderate, fast 
 
Linear Ion Trap 
An ion trap in its simplest definition is a combination of electric and/or magnetic fields to “trap” 
ions. Several types of ion traps exist, of which the quadrupole ion trap is currently one of the 
most broadly used analyzers. The invention of an electrodynamic ion trap was recognized in 
1989 with the Nobel Prize in Physics to Wolfgang Paul and is therefore also often referred to 
as the Paul ion trap. Although these 3D traps are sensitive and relatively inexpensive, they 
have relatively low mass accuracy, due to the limited number of ions that can be accumulated 
in their point-like center before space-charging effects appear. This problem was circumvented 
with the introduction of the linear quadrupole ion trap (Figure 4), where ions are stored in a 
cylindrical volume, which is considerably larger, allowing for increased sensitivity and mass 
accuracy (13). The ions are stored radially by a two-dimensional radio frequency field, and 
axially by stopping potentials applied to end electrodes. Apart from relatively low mass 
accuracy, linear ion trap profit from high sensitivity and very fast scan rates, making them the 
ideal analyzer to be combined with Orbitraps for proteomic applications.  
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Orbitrap 
Another type of (=electrostatic) ion trap, the Orbitrap was patented in 1999 and was presented 
shortly after in 2005 in combination with a LTQ linear ion-trap (15). A high-field compact trap 
version was introduced in 2011 (16). The Orbitrap works in combination with the C-trap, where 
the ions are stored and injected as an ion packet into the Orbitrap. The Orbitrap operates by 
trapping ions in its electrostatic fields in which they orbit around a central electrode and 
oscillate in axial direction. Axial ion frequencies are measured by a non-destructive method in 
which the time-domain signal is recorded by the outer Orbitrap electrodes. The produced signal 
is converted using Fourier transform algorithm (FT) into a mass-to-charge spectrum (Figure 
5). For a detailed explanation on how the Orbitrap works see (17) and (18). The high-field 
Orbitrap is a high resolution mass analyzer reaching a resolving power of >240,000 at m/z 400, 
high mass accuracy of < 2 ppm and a dynamic range greater than 5,000. The potential of the 
Orbitrap is fully revealed when coupled to an LTQ ion trap, configuration discussed in the next 
section.  
 
 
 
Figure 4.  Two dimensional ion trap. Basic design of a two dimensional ion trap. Ions are stored radially by 
a two-dimensional radio frequency field, and axially by stopping potentials applied to end electrodes. 
Adapted from (14) 
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Hybrid ion trap-orbitrap mass spectrometer 
The first commercial instrument including an Orbitrap cell was a hybrid instrument (LTQ 
Orbitrap Classic), which had a linear ion trap in the front-end and the Orbitrap on the back-
end. This instrument combines key qualities required in MS-based proteomics, the high 
resolution – accurate mass (HR/AM) capabilities of the Orbitrap analyzer with the speed and 
sensitivity of the LTQ ion trap (Figure 6). Since the introduction of the Orbitrap, two major 
changes have been made to both analyzers; first, a two-stage LTQ ion trap was introduced 
with the Orbitrap Velos (19), which increased the sequencing speed from 6 to > 12 scans/s 
and two years later a high-field version of the Orbitrap (Orbitrap “Elite”) was presented which 
doubled resolution from 120,000 to 240,000 combined with an enhanced Fourier Transform 
algorithm (eFT) which increases the measuring speed by a factor of 2 (16).  
 
Hybrid mass spectrometers like the LTQ Orbitrap can be used to sequence peptides. This is 
done by combining the strengths of both mass analyzers. A common data acquisition strategy 
is termed High-Low, for high resolution MS1 and low resolution MS2 scan. In order to reduce 
the search space during data base search a high resolution and high accuracy measurement 
is required, therefore the peptide mass is measured in the Orbitrap. After ionization peptides 
are focused into a beam and guided to the C-trap. In the C-trap ions are stored and injected 
as an ion packet into the Orbitrap. Ions start orbiting around the central electrode; at this point  
 
 
Figure 5.  Cross-section of the Orbitrap analyzer. Ions are stored in the C-trap and injected as an ion packet 
into the Orbitrap. Ions are radically trapped in static electrostatic fields. Ions orbit around a central 
electrode and oscillate in axial direction. Ion frequencies are measured and the produced signal is 
converted using Fourier transform algorithm (FT) into a mass-to-charge spectrum. Adapted from 
(15) 
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the ion frequencies are recorded. The signal produced is independent of rotational motion and 
therefore the m/z values of the ions can be calculated. 
 
Based on this MS1 or full-scan, the peptides with the highest intensity are selected for 
fragmentation (MS/MS) in a process termed data-dependent analysis (DDA). The chosen ions 
are consecutively isolated, fragmented and recorded in MS/MS (or MS2) spectrum (Figure 7). 
For MS/MS measurements, high mass accuracy is less critical, but speed and sensitivity are 
very important. Fragmentation usually occurs in the ion trap in a process called collision 
induced dissociation (CID). During this process the peptides are fragmented by high-energy 
collision with a noble gas (e.g. helium). This process fragments peptide ions, with each 
individual peptide broken only on one place on average. Most commonly cleaved bonds are 
peptide bonds, giving rise to sequence-specific b- and y- fragment ions. The m/z ratios of all 
charged fragments are recorded in the LTQ. Another acquisition strategy also frequently used 
is termed “High-High” (16). In this approach both MS1 and MS2 measurements are performed 
at high accuracy and mass resolution in the Orbitrap analyzer. In this strategy peptide 
sequencing is done using high energy collision dissociation (HCD). This strategy results in 
HR/AM measurements of MS2 spectra, which is very useful for the analysis of PTMs, at the 
cost of sequencing speed.  
 
LC-MS/MS 
The speed of this hybrid Orbitrap instrument makes it the ideal instrument to be coupled to 
high performance liquid chromatography (HPLC or LC) through ESI. Since ESI is a technique 
that profits from low solvent amounts it is an advantage to couple MS to nano-LC systems. 
The technique of choice to separate peptides before ionization is reversed-phase 
chromatography. In this method peptides are separated based on their hydrophobicity. The  
 
 
 
Figure 6.  Schematic for the LTQ Orbitrap Elite hybrid mass spectrometer. Ions are transmited from the 
linear ion trap to the C-trap before being injected into the Orbitrap. Adapted from (16). 
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capillary chromatographic column is filled with a reversed-phased material, normally alkyl 
chains bonded to a solid support. The most used alkyl length is octadecyl carbon chain (C18), 
since it is compatible with general properties of peptides. The peptides bind to this C18 material 
and are eluted with a hydrophobic mobile phase (acetonitrile) by increasing its concentration 
over time. A key development in RPLC has been the use of long, narrow capillary RP columns, 
whose advantages include capacity, sensitivity, dynamic range, peak capacity, sensitivity and 
reproducibility (21). Although reversed phase has established itself as the backbone in MS-
based proteomics, the following types of chromatography can also be used: strong anion 
exchange (SAX) or strong cation exchange chromatography (SCX), hydrophilic-interaction 
chromatography (HILIC) and affinity chromatography or a combination of one or more of these 
types of chromatographies (e.g. MUDPIT (22)). 
 
 
 
Figure 7.  MS, MS/MS spectra and peptide ion fragmentation. On the top panel a typical MS and MS/MS 
patterns are shown. A peptide is chosen from the full scan (MS) based on its intentity and 
fragmented. Fragment ions (MS/MS) are recorded in the linear ion trap. In the lower panel the 
different types of fragmentation along the peptide backbone are presented. The peptide fragments 
retaining the positive charge on the N-terminal are refered to as a, b and c, and the fragments 
retaining the positive charge on the C.terminal are refered as x, y, and z. Lower panel adapted from 
(20) 
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Data processing and database search 
The workflow presented so far generates thousands of MS/MS spectra per hour of analysis 
making manual validation of each spectrum almost impossible. The recorded data is 
processed using bioinformatics approaches. The generated spectra are compared against a 
protein database, making the availability of sequencing data for the organism of interest a 
prerequisite. The analysis of this data and its assignment to peptides sequences and the 
determination of its abundance is a complex computational and statistical challenge. Several 
approaches have been developed over the years to automatically assign peptide sequences 
to fragment ion spectra. These approaches can be grouped into three categories (23):  
 
(1) Database searching: ion fragments (MS/MS spectra) are correlated to theoretical spectra 
predicted for each peptide contained in a protein database or by correlating ion fragments 
to spectral libraries from spectra identified in previous experiments. 
(2) De novo sequencing: peptide sequences are read directly from ion fragments. 
(3) Hybrid approaches: extraction of short sequence tags of 3-5 residues followed by an 
organism specific database search. 
Due to the nature of large scale MS-based proteomics, the most used approach is database 
searching, and this approach will be discussed in detail in the next section. 
 
 
Figure 8.  Database search: Target-decoy strategy for FDR assessment. In this strategy all MS/MS 
spectra are searhced against a target/decoy database. The best match for each spectrum is 
integrated in a list containing all identified peptides and sorted by score. The number of decoy 
peptide mathces is used to estimate the false discovery rate (FDR) after filtering the data using 
several score thresholds. Adapted from (24). 
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Database searching and statistical analysis 
In this approach the fragment ion spectrum of a peptide is scored against theoretical 
fragmentation patterns from the searched database (Figure 8). The size of this database 
(database search space) depends, apart from the number of proteins contained in the 
database, on the user-specified criteria such as mass tolerance, enzyme, missed cleavages 
and PTMs allowed. This search generates a list of matches ranked according to the search 
score, the best scoring peptides are then used for the subsequent analysis. The search score 
reflects how good an experimental spectrum matches a theoretical spectrum. There are many  
different scoring approaches available such as MASCOT (25), ANDROMEDA (21) , SEQUEST 
(26) and X! TANDEM (27). 
 
From the results obtained from the search engines it is not possible to deduce what hits are 
true matches and which ones are false positives. Therefore it is critical to use statistical tools 
to discriminate true from false positives. To address this issue, proteomics rely on probabilistic 
approaches that provide a statistical measure of confidences and estimates of error rates (23). 
The statistical approaches can be grouped into two categories: target-decoy search (28) and 
empirical Bayes approaches (29). The most established method is the target decoy search, in 
which all the sequences of the database used for the search are reversed and attached to the 
database used for the search. This method assumes both matches to the target (forward 
database) and decoy (“nonsense” database; can be reversed or random) databases follow the 
same distribution. The matches are then filtered using different cut-offs and the corresponding 
false discovery rate (FDR) can be calculated by dividing the number of decoy hits by the 
number of targets above the cut-off. With this method the number of false positives can be 
calculated as the number of decoy matches. 
 
1.3 Quantitative proteomics 
One of the main advantages of MS-based proteomics is the possibility to directly compare two 
or more perturbations in a biological system. Several approaches have been developed each 
containing their respective advantages and disadvantages. The protein quantification can be 
either absolute or relative. An overview of this approaches is presented in Figure 9.  
 
Relative quantification 
There are several strategies for relative quantification, which can be grouped in two groups: 
“label-free” and stable isotope labeling methods (12). Label-free approaches are relatively 
easy to implement, yet they have a drawback that they are very sensitive to experimental 
variation and require acquisition of multiple replicates. These methods use either spectral 
counting or peptide signal intensity to estimate abundance of proteins (30). In the second  
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approach, stable (non-radioactive) isotope labels need to be introduced into one of the samples 
measured; after labeling and biological treatment, the two protein (or peptide) samples are 
mixed and each peptide is typically seen as a “doublet” in the mass spectrum (one member of 
the doublet comes from the “light”- the other from the “heavy”-labeled sample. Stable isotope 
labeling can be performed metabolically, chemically or enzymatically (32). Enzymatic labelling 
usually incorporates 18O after or during digestion and it is not very widely used. Chemical 
introduction of labels can be done at the protein or at the peptide level. Labels can be 
introduced by e.g. labelling of free cysteines with isotope-coded affinity tags (ICAT) (33), or by 
labelling free amines with tandem mass tags (TMT or iTRAQ) (34) or with dimethyl labeling 
(35). In iTRAQ, quantification is performed using reporter ions in the tandem mass spectra, 
which results in limitations in quantification accuracy (36). Metabolic labeling using stable 
isotopes reduces the variation that can be introduced during sample handling, as it enables 
early mixing of differentially labeled samples. In this method the whole proteome can be 
labeled with a single stable isotope, e.g. 15N (37); alternatively, a defined label can be 
introduced by addition of stable isotope labeled (“heavy”) amino acids in the cell culture. 
Quantification is performed with labeled peptides at the MS level. The most widely used 
 
 
 
Figure 9.  Typical labling workflows in quantitative proteomics. The scheme shows several isotopic 
labelling strategies employed in quantitative proteomics. The two colors represent the two different 
labeling states being compared. The samples are combined with the horizonal lines. The overview 
outlines from what point on samples are processed together and when in parallel (quantification 
errors can ocurr). Adapted from (31). 
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method of metabolic labeling is stable isotope-labeling by amino acids in cell culture (SILAC) 
(38). This method is described in detail in the next section. 
 
SILAC 
In this metabolic labeling approach, amino acids containing stable isotopes are supplied in 
growth media and incorporated into newly synthesized proteins. After several cell doublings 
(usually 6-8) all the proteins will incorporate the added heavy amino acid. After digestion, 
ideally every peptide pair will be separated by the mass difference introduced by the label. 
Arginine and lysine are usually the amino acids of choice because digestion with trypsin will 
result in all tryptic peptides having at least one isotopically labeled amino acid. Alternatively 
only lysine can be used when digesting with endoproteinase Lys-C. It is crucial that the amino 
acid used for labeling is essential, i.e. that it cannot be synthesized by the cell. In some cases 
this can be bypassed by offering an excess of labeled amino acid to the cell or organism, 
although a general method is the generation of strains auxotrophic for the amino acid(s) of 
interest (32).  
 
There are some general limitations when employing SILAC. One of the major challenges faced 
when applying SILAC is the arginine to proline conversion. It has been observed that arginine 
can be metabolically converted to proline in some organisms or cell types (39) (see Figure 1 
Chapter 4). This can be circumvented for example by employing only heavy lysine for labelling 
(40), by titration of arginine and proline concentrations (41) or by computational methods (42). 
Another limitation when using SILAC is that some cell lines are sensitive to changes in the 
medium composition and may not be suitable for metabolic labelling. Also a maximum of three 
conditions can be compared in one experiment, although these has been circumvented by the 
combination of spike-in standards (43) or the use of more than one triple-SILAC experiment 
with a common standard (44). Because of the early combination of samples, SILAC is the most 
accurate quantitative MS method in terms of overall experimental process. This makes it 
especially interesting when assessing changes in levels of proteins or PTMs with low 
stoichiometry.  
 
Absolute quantification  
The methods mentioned before, although important in comparative biological studies, do not 
provide information on absolute protein quantities or concentrations. In the last years several 
techniques for absolute quantification that relays on the addition of a stable isotope labeled 
standard with a known concentration have been developed. The most well-known method is 
AQUA (Absolute QUAntification), in which peptides of known concentration with an 
incorporated stable isotope is spiked into the sample of interest to precisely quantify the 
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absolute amount of the target peptide and therefore of the target protein (45). Other methods 
such as “protein standard absolute quantification” (PSAQ) (46), FlexiQuant (47), and absolute 
quantification using protein epitope signature tags (PrEST) (48) have also been described in 
the literature. A method that has recently gained attention is the intensity based absolute 
quantification (iBAQ) (49); this method combines both label free quantification with a spiked in 
standard. The iBAQ value is calculated by summing all of the peptide intensities from a given 
protein and dividing it by the theoretical amount of MS-observable peptides. Absolute protein 
amounts are then calculated by correlating these values with iBAQ values from a spiked-in 
standard of known concentration. For more detailed description of iBAQ and other factors that 
are important in estimation of absolute protein amounts (e.g. cell count, volume, etc.), please 
refer to section 3.3. 
 
Proteome analysis 
The cell lysate is a very complex mixture of proteins, which becomes even more complex after 
enzymatic digestion. Low abundant proteins (peptides) are difficult to identify by data-
dependent analysis (DDA), since this approach preferentially targets more abundant peptides. 
Lower abundant peptides will also co-elute with more abundant peptides making its 
identification more difficult. It has been calculated that from 100,000 peptides eluting during 
one HeLa lysate measurement only about 16% of them are targeted for MS/MS (50). Therefore 
several approaches have been successfully applied to reduce the complexity of the samples, 
such as subcellular (51), protein (GeLC (52) and gel filtration chromatography (53)), or peptide 
fractionation (Off-Gel (54) and StageTip based fractionation (55)).  
 
Phosphoproteome analysis 
Protein phosphorylation is one of the most important and most abundant posttranslational 
modifications (PTMs) in living cells and it regulates biological process in virtually every known 
organism. It has been involved in cell cycle control, receptor-mediated signal transduction, 
differentiation, proliferation, transformation, and general metabolism (20). Phosphorylation is 
regulated by two types of enzymes with opposite functions – proteins are phosphorylated by 
kinases and dephosphorylated by phosphatases in a highly conserved mechanism that almost 
exclusively involves adenosine triphosphate (ATP). Due to modern global proteomics studies, 
thousands of phosphorylated proteins have been identified, and it has been predicted that 
more than 500,000 phosphorylation sites are present in the human proteome (56). 
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Enrichment of STY-phosphorylated peptides 
Although it has been proven that phosphorylation site stoichiometry (occupancy) can be very 
high during specific cellular processes, such as mitosis (44), protein phosphorylation occurs 
mostly at very low levels (i.e. it is substoichiometric) and its identification is therefore 
challenging. In order to detect phosphorylation events in a global scale, phosphopeptide 
enrichment strategies such as phosphopeptide immunoprecipitation (57), immobilized metal 
ion affinity chromatography (IMAC) (58) or titanium dioxide chromatography (TiO2) (59) need 
to be employed. For example, TiO2 chromatography relies on enrichment through high affinity 
absorption of phosphate groups (TiO2-phosphate complex). A strategy commonly used to 
improve specificity is the addition of DHB, which binds with a higher affinity than acidic amino 
acid residues but with lower affinity than phosphate groups (Figure 10). These strategies in 
combination with technological advances (increase of sensitivity and sequencing speed) have 
resulted in the publication of large phosphoproteomic datasets produced in our laboratory 
(among others) for human (60), nematodes (61), bacteria (62, 63) and yeast (40).  
 
Phosphorylation site stoichiometry (occupancy) 
Protein phosphorylation is a dynamic process and not all molecules of a given protein are fully 
modified at specific residues all times – this phosphorylation site “occupancy” (stoichiometry) 
can be as low as <1% (i.e. one protein molecule in 100 is phosphorylated), or as high as 100% 
(all molecules are modified). Phosphorylation site occupancy has severe implications on the 
signaling potential of a protein and its extent is necessary for systems biologists to better 
understand regulation of biological process and to distinguish between functional and non-
functional phosphorylation. Determining the occupancy of phosphorylation sites is now 
possible in large scale and two different equally successful approaches have been employed 
(44, 64). The first approach, also used in this study, calculates stoichiometry using SILAC ratios  
 
 
 
Figure 10.  Complexes of compounds commonly used for enrichment of phosphorylated peptides. On 
the left coordination of the a phosphate group to a immobilized metal, strategy used with IMAC. On 
the right TiO2-DHB complex. DHB binds with a higher affinity than acidic amino acid residues but 
with a lower affinity than phosphate groups, increasing the specificity of TiO2. Figure adapted from 
(20) 
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of the phosphorylated peptide, the un-phosphorylated version of the same peptide and the 
protein ratios (Figure 11). The second approach calculates stoichiometry by treating a fraction 
of the sample with phosphatase and then comparing relative peak intensities from both treated 
and non-treated fractions. 
 
Acetylome analysis 
Lysine acetylation is a reversible PTM that has been related to multiple cellular processes such 
as transcription-related processes (65), metabolic regulation (66), chromatin remodeling, cell 
cycle, splicing, nuclear transport and actin nucleation (67). Lysine acetyltransferases (KATs) 
transfer an acetyl group to the ɛ-amino group of a lysine, therefore neutralizing the positive 
charge of this amino acid. The acetyl group is removed by lysine deacetylases (KDACs). Its 
role in gene regulation by histone modification has been deeply characterized and it was where 
it was originally discovered (68). Apart from histones a large number of proteins have been 
found to be lysine acetylated. Lysine residues are modified by other PTMs (methylation, 
ubiquitination, sumoylation, etc.), therefore there is a potential for cross-talk with this 
modifications. Furthermore, adjacent amino acids can also be modified presenting a potential 
for interplays between different PTMs. Some of this interplays have been shown to have 
important functional roles (69, 70). In the first large-scale lysine acetylation, Choudhary and 
colleagues involved lysine acetylation in diverse cellular processes (67). After this, several 
large-scale studies in several organisms like mouse (71), budding yeast (72), salmonella (73), 
Drosophila (74) and Escherichia coli (75) were published. 
 
1.4 Fission yeast as a model organism 
Schizosaccharomyces pombe, commonly known as fission yeast, is a unicellular eukaryotic 
organism that is amenable to genetic manipulation and carries many cell cycle features similar 
to cells from multicellular organisms. Fission yeast is an established model organism to study 
 
 
Figure 11.  Phosphorylation site soichiometry calculation. Example for the calculation of phosphorylation 
site occupancy based on three ratios: phosphopeptide, non-phosphopeptide and protein ratio. The 
phosphosite stoichiometry is calculated based on the proportion for each labelling state. Figure 
adapted from (44). 
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processes such as cell cycle and checkpoint controls (76). Fission yeasts grow by elongating 
at both ends and divides by forming a wall through the middle of the cell. The length of the cell 
indicates its position in the cell cycle, making it the ideal organism to study cell cycle. Recent 
global proteomics studies of yeasts and their cell cycle (77-83) have mainly focused on 
Saccharomyces cerevisiae (budding yeast), with only few studies of fission yeast (84, 85), 
although the fission yeast cell cycle may be more representative of eukaryotic cell cycles (86). 
Recently, global studies of the fission yeast have been published covering up to 3,542 S. 
pombe proteins (71% of the predicted proteome) and 1,544 phosphorylation events in both, 
asynchronous and synchronized cell cultures (40, 87-90). 
 
Cell cycle of fission yeast 
Cell division requires a delicately orchestrated sequence of complex biochemical events that 
assures that every daughter cell obtains all the components required for survival. 
Investigations into the control of cell division in diverse cells have revealed universal regulatory 
mechanisms. Signaling mechanisms determine whether and when a cell undergoes cell 
division, and ensure orderly passage through the stages of the cell cycle. When the regulatory 
mechanisms that limit cell division are defective, the cells undergo unregulated division which 
could potentially result in cancer. Since a detailed understanding of the cell cycle and its 
 
 
Figure 12.  The cell cycle phases. Cell cycle of (A) fission yeast and (B) budding yeast. The cell cycle of most 
organisms is divided in four main phases: M, G1, S, and G2. M phase (mitosis) is usually followed 
by cell division. S phase (synthesis) is the period during which DNA replication occurs. G1 and G2 
(gap) are waiting periods. Adapted from (91) 
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regulation may lead to the identification of additional targets for cancer therapy, it is crucial to 
understand these underlying mechanisms (92-94). 
 
The cell cycle has four major stages. In the S phase (synthesis), DNA is replicated. This is 
followed by G2 phase (or Gap phase), where proteins are synthesized before entering M phase 
(mitosis). During M phase the nuclear envelope breaks down, paired chromosomes are pulled 
to opposite poles of the cell, before being surrounded by a newly formed nuclear envelope, 
and cytokinesis pinches the cell in half, resulting in two daughter cells. Before starting cell cycle 
again cells go again though a waiting period called G1 phase (95) (Figure 12). The events that 
take place during these phases must be coordinated with one another so that they occur in the 
appropriate order. This coordination of the cell cycle depends on several checkpoints and 
feedback controls that prevent entry into the next phase until the events of the proceeding 
phase have been completed (92).  
 
The cell cycle is controlled by protein kinases. By phosphorylating specific proteins at precise 
time points, these protein kinases organize biochemical events of the cell that result in cell 
division. The typical cell cycle kinases are heterodimers with a regulatory subunit, cyclin, and 
a catalytic subunit, cyclin dependent protein kinase (CDK). In the absence of the cyclin, the 
catalytic subunit is virtually inactive. When cyclin binds, the catalytic site opens up, a residue 
essential to catalysis becomes accessible and the activity of the catalytic subunit increases 
10,000-fold. Animal cells have at least 10 different cyclins and at least 8 CDKs, which act in 
various combinations at specific points in the cell cycle (95). CDK activities oscillate during the 
cell cycle as a result of regulation through phosphorylation or dephosphorylation of the CDK, 
controlled degradation of the cyclin subunit, periodic synthesis of CDKs and cyclins, and action 
of specific CDK-inhibiting proteins. In general, active CDKs enable a cell to enter a stage of 
cell division. The list of proteins that CDKs target continues to expand and the phosphorylation 
of key proteins at specific points in the cell cycle is key in modulating its activities. In the 1970s 
Paul Nurse identified a gene (cdc2) that when mutated would cause the growth of cells at 
elevated temperature to stop at certain points in the cell cycle (96). This identification was later 
recognized in 2001 with the Nobel Prize in Physiology or Medicine. In fission yeast cdc2 is 
responsible for both transition points at G1 and G2. After the first transition point in late G1, 
the cell commits to replicate its DNA. This pass requires activation of Cdc2 by G1 cyclins 
(levels rise during G1). This activation leads to replication at sites where pre-replication 
complexes had previously assembled (97).  
 
The G2/M passage requires activation by mitotic cyclins. Cdks containing a mitotic cyclin 
phosphorylate substrates that are required for the cell to enter mitosis. The substrates include 
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proteins required for changes in organization of the chromosomes and cytoskeleton. Exit from 
mitosis and entry into G1 depend on a rapid decrease in Cdk activity that results from a drop 
in concentration of the mitotic cyclins. When the cell reaches a critical size, the cdc25 
phosphatase is activated and removes the inhibitory phosphate on Tyr 15 residue. The 
resulting activation of cdc2 kinase drives the cell into mitosis (97). The mutation of the cdc25 
gene results in cells that do not divide but continue to grow. A temperature sensitive mutation 
of this gene was used to arrest cells in one study presented later (98).  
 
MS-based proteomics is the ideal tool to study protein dynamics and phosphorylation 
dynamics during the cell cycle. In a very comprehensive study Olsen et al. (44) measured the 
dynamics of thousands of proteins and phosphorylation events across cell cycle phases of 
HeLa cells, providing insights into the underlying regulatory mechanisms. In this study they 
found out that many phosphorylation sites have very high occupancy (>90%) and that in 
general there is an increase in occupancy during M phase. In another study, Pagliuca et al. 
(99) investigated proteins that interact with cyclins in HeLa cells. In this study they identified 
mechanisms by which cyclin-cdks control the cell cycle and characterized the interaction 
between DNA replication and mitosis giving insight into the cell cycle machinery.  
 
SILAC labelling in fission yeast 
Quantitative proteomics based on metabolic labeling require full incorporation of labeled amino 
acids. As discussed above, some organisms have the ability to convert arginine to proline, 
which results in tryptic peptides containing heavy proline (100). To circumvent this problem 
several experimental and bioinformatics approaches have been developed (41, 101-103). The 
degree of conversion varies from organism to organism. S. pombe is especially efficient and 
researchers need to deal with this problem. This can be by-passed by either employing stable 
isotope-marked lysine only (40) or by using strains that only very inefficiently convert arginine 
to proline (104). These approaches although successful have certain limitations. These 
limitations are thoroughly discussed in paper 2 as well as an experimental strategy to 
circumvent these issues.  
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1.5 Aims 
The overall goal of this thesis is to develop mass spectrometry based strategies for the study 
of fission yeast and its cell cycle. The strategy followed a three step process: 1) optimization 
of quantitative proteomics and phosphoproteomics methods, 2) study of the absolute proteome 
and phosphoproteome dynamics during the cell cycle of the fission yeast and 3) solving the 
“Arg10 labelling” problem in fission yeast and. The specific aims are: 
 
1. Optimization of quantitative proteomics and phosphorylation and acetylation enrichment 
methods 
a. Eliminate the use of DHB in order to decrease chemical noise in the sample. 
b. Improve phosphopeptide enrichment using lower protein amounts. 
c. Establish a lysine acetylation enrichment method.  
2. Study of the absolute proteome and phosphoproteome dynamics during the cell cycle of 
the fission yeast 
a. Increase the understanding of the cell cycle and its regulation through 
characterization at both proteome and phosphoproteome level. 
b. Measure relative and absolute dynamics of the proteome and phosphoproteome 
during the cell cycle of fission yeast. 
c. Estimate copy numbers of proteins. 
d. Calculate phosphorylation site stoichiometry. 
e. Estimate total amount of protein-bound phosphate, its dynamics across the cell 
cycle and implications for overall ATP consumption during the cell cycle.  
3. Solving the “Arg10 labelling” problem in fission yeast  
a. Improve the standard growth media and adapt it for SILAC experiments. 
b. Enable the use of heavy arginine. 
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2.1 Abstract 
Shot-gun proteomics combined with Stable Isotope Labeling by Amino acids in Cell culture 
(SILAC) is a powerful approach to quantify proteins and post-translational modifications across 
the entire proteome. Use of SILAC technology in S. pombe needs to cope with the “arginine-
conversion problem”, in which isotope-labeled arginine is converted to other amino acids. This 
can be circumvented by either employing stable isotope-marked lysine only (as opposed to the 
more standard lysine/arginine double labeling), or by using the power of yeast genetics to 
create strains that only very inefficiently convert arginine to proline. Both strategies have been 
employed successfully in S. pombe large-scale (phospho)proteomics projects. Here we 
present a (phospho)proteomic workflow based on in-solution proteome digestion of SILAC-
labeled samples, phosphopeptide enrichment using strong cation exchange and TiO2 
chromatographies, followed by high accuracy mass spectrometry measurement on an Orbitrap 
mass spectrometer and subsequent bioinformatic processing using MaxQuant software. 
 
2.2 Introduction 
Shot-gun proteomics has emerged as state-of-the-art technology to globally identify and 
quantify proteins and post-translational modifications using liquid chromatography combined 
with mass spectrometry (LC-MS). This technique, in which the complete proteome is digested 
into peptides for analysis, is by itself semi-quantitative and needs to be combined with other 
chemical, biological or bioinformatic techniques to yield quantitative data (1-4). 
  
Although many shot-gun proteomics studies have focused on Saccharomyces cerevisiae (5-
11), attention of the proteomics community towards S. pombe is increasing. Several 
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comprehensive proteomic and phosphoproteomic studies have recently been published (12-
19). So far these studies have covered up to 3,542 S. pombe proteins (71 % of the predicted 
proteome) (19) and 1,544 phosphoproteins (17) and have examined the S. pombe proteome 
under various physiological conditions. 
 
SILAC (Stable Isotope Labeling by Amino acids in Cell culture) is an elegant method for relative 
quantification of peptides and proteins from different samples (3, 20). SILAC involves 
metabolic labeling of cells with exogenous amino acids containing defined numbers of stable, 
non-radioactive, “heavy” isotopes (e.g. 2H, 13C and 15N), thereby introducing a defined isotope 
label into newly synthesized cellular proteins. In parallel, a separate cell culture is grown in 
presence of the corresponding natural “light” amino acids. “Heavy” and “light” cultures can 
either correspond to two different treatments or growth conditions of the same strain, or two 
different strains altogether. Upon completion of the experiment, cells are lysed, and the “heavy” 
and “light” lysates are mixed in equal amounts according to cell count or protein content. The 
combined protein extract is then digested with an appropriate protease, and the resulting 
peptide mixture is measured in a mass spectrometer. In a SILAC MS measurement, peptide 
ions are detected as doublets, and the total signal ratio between the members of a doublet 
corresponds to the relative difference in the amount of the relevant protein or peptide (e.g. for 
a post-translational modification) between the two analyzed states (Figure 1). Because most 
of the amino acids used for labeling allow for synthesis of two different “heavy” forms, SILAC 
can be extended to three samples at once, often called “heavy”, “medium-heavy” and “light”; 
in this case, peptide ions are detected as triplets. 
 
For labeling cells, an ideal SILAC growth medium will contain both “heavy” arginine and 
“heavy” lysine. The reason is that trypsin, which is the standard protease for digestion of 
proteins (because it typically creates peptide sizes suitable for MS), cleaves polypeptide chains 
after arginine and lysine residues. Labeling with “heavy” arginine and lysine therefore ensures 
that all peptides contain at least one “heavy” amino acid after digestion and therefore are 
quantifiable (due to incomplete digestion, some peptides may contain more than one “heavy” 
amino acid). Because wild-type S. pombe can synthesize all amino acids, labeling cells with  
“heavy” amino acids requires the use of auxotrophic strains. Labeling fission yeast lysine 
auxotrophic cells with “heavy” lysine is straightforward and does not present any problems (17, 
21). However, arginine is catabolized and converted into other amino acids, including but not 
limited to proline. As a result, “heavy” label can be incorporated into proteins at amino-acid 
residues other than arginine, leading to the appearance of additional peaks in MS and MS/MS 
spectra of a given peptide. This so-called “arginine-conversion problem” can seriously 
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confound peptide identification and quantification. In addition, certain auxotrophs in fission 
yeast, including lysine/arginine double auxotrophs, can show impaired growth even in the 
presence of the required amino acids. Therefore, SILAC experiments in fission yeast face two 
important issues: 1) avoiding catabolic conversion of labeled arginine to other amino acids; 
and 2) obtaining robust growth of auxotrophic strains used in labeling experiments. 
 
 
Figure 1.   SILAC-based phosphoproteomics workflow described in this protocol. 
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In mammalian cells and budding yeast, arginine-conversion is minor, and several approaches 
have been developed to minimize the problem, including titration of arginine and proline 
concentrations and computational methods (20, 22-28). In fission yeast, arginine-conversion 
is much more extensive (16) and thus must be dealt with more decisively. Two general 
approaches are possible, and both have been used successfully (16, 17). The first approach 
(17) avoids “heavy” arginine altogether. Instead, cells are labeled only with “heavy” lysine, and, 
in place of trypsin, proteolytic digestion into peptides is performed using lysyl endopeptidase 
Lys-C, which cleaves after lysine residues. While this approach is technically straightforward, 
a potential disadvantage is that peptides produced by Lys-C digestion will be significantly 
longer than those produced by trypsin. This can affect “flyability” of peptides and thus 
identification in the mass spectrometer. The second approach (16) takes advantage of the 
power of yeast genetics and deletes genes that encode enzymes involved in arginine 
catabolism, thereby preventing or at least decreasing arginine-conversion. Deletion of the 
predicted ornithine transaminase gene car2+ or simultaneous double-deletion of the redundant 
predicted arginase genes car1+ and aru1+ has been shown to decrease conversion to 
acceptably low levels (16). Because constructing single-deletion strains is easier, deletion of 
the car2+ gene has generally been the preferred method. 
 
Here we describe a protocol for constructing fission yeast strains suitable for SILAC MS, as 
well as conditions for robust growth, harvesting, and processing of cells (16, 17). We further 
describe a protocol for enrichment and analysis of protein Ser/Thr/Tyr phosphorylation in 
fission yeast using strong cation exchange (SCX) and TiO2 chromatography, followed by LC-
MS measurement. This strategy has been used in several large-scale phosphoproteomics 
studies in both eukaryotes (29, 30) and prokaryotes (31, 32). The protocol follows methods 
outlined in (33) (Figure 1) and presents a revised version of a previously published protocol 
(34). Parts of this protocol can be applied to enrichment and analysis of other post-translational 
modifications: for example, SCX can be used to enrich for N-terminal acetylation (35), and TiO2 
can be used to enrich for sugars containing negatively charged residues, such as sialic acid 
(36). In this chapter we focus on enrichment of phosphopeptides and note how the protocol 
can be adapted for proteome analysis. Other methods can be used if deeper proteome 
coverage is required (37, 38).  
 
2.3 Method 
In-solution protein digestion 
1. Dissolve the protein sample in denaturation buffer at RT to a final concentration between 
2 and 5 mg/mL. 
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This protocol is optimized for protein amounts between 2 and 10 mg. We recommend using 
at least 5 mg of protein to achieve good coverage of the phosphoproteome. Do not heat-
up samples in the presence of urea; high concentration of urea will lead to carbamylation 
of free amino groups. Keep the salt concentration at a minimum during all steps, salt 
concentrations above 10 mM may interfere with SCX chromatography. 
2. Add reduction buffer to a final concentration of 1 mM DTT and incubate under mild shaking 
conditions for 1 h at RT. 
3. Add alkylation buffer to a final concentration of 5.5 mM IAA and incubate under mild 
shaking conditions for 1 h at RT in the dark. 
4. Check pH using a pH indicator strip and adjust to 8.0 if necessary. 
Adjust the pH with a very low volume of 1M Tris-HCl, pH 8.0. 
5. Add 1 µg of lysyl endopeptidase LysC per 100 µg of protein and incubate under mild 
shaking conditions for 3 h at RT. 
6. Dilute the sample 1:5 with Milli-Q water. 
7. Add 1 µg of trypsin per 100 µg of protein. 
If samples are only labeled with lysine, add another 1 µg of lysyl endopeptidase LysC per 
100 µg of protein instead of trypsin. 
8. Check pH and adjust to 8.0 if necessary. Incubate overnight (ca. 18 h) under mild shaking 
conditions at RT.  
The pH of the sample may change after digestion is completed, furthermore trypsin is 
stored in acidic conditions and the pH of the sample may change after trypsin has been 
added. Adjust the pH with a very low volume of 1M Tris-HCl, pH 8.0. At this point the protein 
digest can be directly measured by LC-MS (proteome measurement). In this case skip the 
“SCX Chromatography” and “TiO2 Chromatography” protocols and continue with “Liquid 
Chromatography”.  
 
SCX Chromatography 
9. Quench the digestion reaction by adding trifluoroacetic acid (TFA) to a final concentration 
of 0.1% (vol/vol). Incubate for 10 min at RT while shaking. 
Make sure that the pH is <2.7. If necessary, add more TFA, but keep the TFA 
concentration as low as possible. Usually a maximum of 0.3% TFA is required.  
10. Centrifuge the sample for 5 min at 3,000 g to remove precipitate. Transfer supernatant to 
a new tube and discard the precipitate. 
The precipitate contains mainly urea. 
11. Load the protein digest onto an equilibrated SCX column with SCX solvent A at a flow rate 
of 1 mL/min. 
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If salt concentration is higher than 10 mM dilute sample with Milli-Q water. Conductivity 
during sample loading should be under 4 mS/cm since higher conductivity can interfere 
with peptide binding; if higher conductivity is observed flow-through should be diluted with 
Milli-Q water and reloaded onto the column.  
12. Collect the flow-through. 
Collection and subsequent phosphopeptide enrichment and analysis of the flow-through is 
particularly important since multiply phosphorylated peptides will not bind to the SCX 
column. 
13. Elute the bound peptides with a linear gradient of 0 – 30% SCX solvent B over 30 minutes 
at a flow rate of 1 mL/min, collect the eluent in 2 mL fractions. 
 
TiO2 Chromatography 
14. Each SCX fraction, including the flow-through, is incubated with separate batches of TiO2 
beads and will be referred as “FT” (Flow-Through) or “Fraction” in the text. 
15. Desalt peptides from FT using reversed-phase Sep-Pak C18 cartridges. 
The FT fraction contains a high amount of Urea. Each cartridge has a binding capacity of 
around 18 mg of protein. 
16. Lyophilize the FT and each fraction separately. Dried peptides can be stored at −80 °C for 
several weeks. 
Drying samples for phosphopeptide enrichment for longer periods in the vacuum centrifuge 
is not recommended. Vacuum centrifuging usually involves increase in temperature, which 
could affect some labile phosphorylation events. In addition, drying to completeness 
usually leads to low recovery of (phospho)peptides from the walls of centrifuge tubes.  
17. Re-dissolve the FT in 10 mL of loading solution and the fractions in 2 mL of loading solution. 
Alternatively the fractions can be adjusted to a final concentration of 80% ACN and 6% 
trifluoroacetic acid by adding ACN and TFA directly to the FT and the fractions. The 
fractions (not the FT) contain 30% ACN so a final concentration of 80% ACN and 6% TFA 
can be achieved by adding 7400 µL ACN and 600 µL TFA per fraction. 
18. Weigh TiO2 beads into a dedicated tube; for each round of enrichment weigh 5 mg of 
beads. 
We recommend performing five successive rounds of enrichment for the FT and three for 
the first 5 SCX fractions. These fractions usually contain the highest amount of 
phosphopeptides and performing serial enrichment of these samples will increase the 
amount of phosphopeptides identified.  
19. Wash TiO2 beads by adding 50 µL of washing solution per 5 mg of TiO2 beads, centrifuge 
and discard supernatant.  
20. Resuspend beads with 50 µL of washing solution per 5 mg of TiO2 beads. 
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21. Spike 50 µL of TiO2 beads in washing solution separately into each sample. 
22. Mix 30 min at RT using an orbital shaker. 
23. Centrifuge at 10,000 g for 2 min then remove and keep the supernatant. 
24. For successive rounds of enrichment repeat steps 7 – 9 with the supernatant as required. 
Each successive round of enrichment will generate a new bead sample and should be 
treated separately. 
25. Wash beads twice with 1 mL wash solution, incubate with shaking in a Thermomixer at 850 
rpm at RT for 10 min. Centrifuge at 10,000 g for 2 min and discard supernatant. 
26. Prepare one C8 microcolumn (“stage-tip”) for each sample by placing a ~1 mm2 piece of 
Empore C8 material into a 200 µl (yellow) pipette tip, as described previously (39). 
C8 microcolumns can also be commercially obtained (SP301, Thermo Fisher Scientific). 
27. Resuspend beads in 50 µL of wash solution and transfer to a C8 microcolumn. 
28. Pack column at 2,000 g for 3 min and discard flow-through. 
29. Elute each sample with 3 x 100 µL of elution solution. 
30. Dry the eluates to a final volume of 100 µL in a vacuum centrifuge. 
31. Add formic acid to a final concentration of 1%. 
32. Check pH, should be <2.7. 
Samples can be further dried to a final volume of 5 µL and measured directly, which may 
rescue very hydrophobic phosphopeptides. 
33. Desalt peptides as described previously (39). 
 
Liquid chromatography 
34. Pack the nano-emitter with 15 cm of reversed-phase C18 with methanol at a constant 
helium pressure of 80 bar using a pressure injection cell.  
Alternatively pre-packed columns can be acquired commercially, e.g. PicoFrit column 360 
µm OD x 75 µm ID, 8 µm Tip ID, 15 cm length packed with Reprosil-PUR C18 AQ, 3 µm, 
120 Å (PF7508-150H354, New Objective). 
35. Set the system with a liquid junction, with no pre-column and no split by connecting the 
column (Packed Emitter) to a PEEK MicroCross. Attach to the MicroCoss the “waste in” 
and “column out” lines as well as a platine electrode to supply the spray voltage. 
For a more detailed protocol please refer to Schieltz et al. (40). 
36. Elute samples from StageTips with 50 µL HPLC solvent B and dry in the vacuum centrifuge 
to a final volume of 5 µL. 
If sample is <5 µL adjust volume with HPLC solvent A. Do not let the sample dry and do 
not use temperature while drying. 
37. Add 1 µL of HPLC loading solvent to the sample. 
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38. Load 5 µL of the phosphopeptide sample onto the column at a fixed flow rate of 0.7 µL/min, 
limiting pressure to 280 bar using the Intelliflow option. 
This method was developed with an HPLC. A UHPLC can also be used and the parameters 
should be adjusted accordingly. 
39. Equilibrate the analytical column. 
40. Elute the peptides using a 120 min linear gradient from 5 – 30 % solvent B at a flow of 200 
nL/min. 
41. Wash-out hydrophobic peptides by linearly increasing the concentration of solvent B to 50 
% over 10 min. 
42. Wash the column with 90 % solvent B for 5 min. 
43. Equilibrate column with 5 % solvent B before next sample is measured. 
 
Mass spectrometry 
44. Samples are analyzed using liquid chromatography tandem mass spectrometry (LC-
MS/MS). This protocol has been performed using an Easy-nLC II connected to an LTQ 
Orbitrap Elite (Thermo Fisher Scientific) using a nano-electrospray source. 
To perform this type of analysis, any nanoflow LC connected to a high resolution mass 
spectrometer can be used. 
45. Operate the mass spectrometer using data-dependent acquisition mode. In this mode a 
defined number of precursor ions from the survey scan or full MS are selected for further 
MS/MS analysis.  
46. Analyze the samples using the parameters described in table 1. 
Two data-dependent methods are presented here. For high-accuracy and full mass range 
measurements of fragment ions the HCD method is recommended. The CID MSA method 
yields a fast-scanning and high-sensitivity but low resolution measurements of fragment 
ions. We prefer using the HCD method which usually yields better spectra for modified 
peptides and facilitates localization of phosphorylation sites due to high-accuracy. We 
recommend to use the CID method in older versions of the Orbitrap instruments (e.g. 
Orbitrap Classic and Orbitrap XL) since HCD sequencing is considerably slower than CID 
in these instruments.  
 
Data processing and Analysis 
47. We routinely use the MaxQuant software suite (41-44) to process phosphoproteomics data. 
Download and install the latest MaxQuant version ensuring that the software and hardware 
requirements are fulfilled.  
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Alternatively there are several freely or commercially available software packages that can 
manage phosphoproteomics data (e.g. Mascot, Proteome Discoverer, Scaffold, Trans-
Proteomic Pipeline, etc.). 
48. Load all the files into MaxQuant. Use predefined parameters unless stated otherwise (see 
below). 
Make sure that all the files are located in one folder. If many files are going to be loaded 
the load file option can be used. 
49. Create an experimental template after loading the files by pressing the “Write Template” 
icon.  
A file named experimentalDesignTemplate.txt will be created in a subfolder called 
“combined” in the folder containing your raw files.  
50. Open experimentalDesignTemplate.txt using any txt reader (eg. Excel) and define your 
experiment accordingly. 
As many experiments as required can be defined. Our recommendation is to group all the 
samples corresponding to one biological replicate into one experiment and to define 
replicates as separate experiments (eg. BiologicalReplicate1 and BiologicalReplicate2). If 
proteome measurements were performed in parallel define these also separately.  
51. Load the experimental template using the “Read from” file icon.  
52. In the “Group-specific parameters” Tab define multiplicity and the used labels, add 
Phospho(STY) as variable modification and specify the used enzyme.  
Multiplicity will be depending on the number of channels used in the experiment, in a 
double-SILAC experiment and triple-SILAC experiment the multiplicity will be 2 and 3, 
respectively. If proteome only samples were measured an extra experimental group can 
be defined in the “Raw files” tab – a new group tab will appear under “group specific 
parameters” – search this files without Phospho(STY) as variable modification, all other 
parameters will be the same. 
53. Under the “Global parameters” tab add the fission yeast fasta file for the database search. 
The fasta file can be downloaded from online resources such as PomBase 
(www.pombase.org) or UniProt (www.uniprot.org). The exact version and date of download 
should be recorded - this information will be required when the data is published. 
54. Define the number of threads and start the processing. 
The number of threads should be equal or lower than the number of cores available, 
although at least 2 GB per thread are recommended. 
55. Once the processing is completed, a folder named “txt” will be created in the “combined” 
folder. This folder contains the result files in txt format which can be opened and analyzed 
using Excel. 
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The “txt” folder also contains a file named tables.pdf which contains an extensive 
description of the files generated in this folder as well as the columns contained in each 
table.  
 
2.4 Contributions 
This protocol is part of a book chapter in a laboratory manual on fission yeast published by 
Cold Spring Harbor Laboratory Press in 2014. André Koch, Claudia C. Bicho, Weronika E. 
Borek, Silke Hauf, and Kenneth E. Sawin were mostly involved in the other components of the 
chapter and participated with comments, suggestions and helped writing the introduction. Boris 
Macek developed the original protocol and together with me wrote the protocol. I optimized 
and established the protocol presented here. My contribution to this manuscript was about 
70%. 
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3. Absolute proteome and phosphoproteome dynamics during the cell cycle of fission 
yeast (Manuscript II) 
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Carpy, A., Krug, K., Graf, S., Koch, A., Popic, S., Hauf, S., and Macek, B. (2014) Absolute 
proteome and phosphoproteome dynamics during the cell cycle of fission yeast. Molecular & 
cellular proteomics, in press, doi: 10.1074/mcp.M113.035824 
 
3.1 Abstract 
To quantify cell cycle-dependent fluctuations on a proteome-wide scale, we performed 
integrative analysis of the proteome and phosphoproteome during the four major phases of 
the cell cycle in S. pombe. In highly synchronized cells we identified 3,753 proteins and 3,682 
phosphorylation events and relatively quantified 65 % of the data across all phases. 
Quantitative changes during the cell cycle were infrequent and weak in the proteome, but 
prominent in the phosphoproteome. Protein phosphorylation peaked in mitosis, where the 
median phosphorylation site occupancy was 44 %, about two-fold higher than in other phases. 
We measured copy numbers of 3,178 proteins, which together with phosphorylation site 
stoichiometry enabled us to estimate the absolute amount of protein-bound phosphate, as well 
as its change across the cell cycle. Our results indicate that 23 % of the average intracellular 
ATP is utilized by protein kinases to phosphorylate their substrates in order to drive regulatory 
processes during cell division. Accordingly, we observe that phosphate transporters and 
phosphate-metabolizing enzymes are phosphorylated and therefore likely to be regulated in 
mitosis.  
 
3.2 Introduction 
Cell replication involves a complex series of highly regulated and evolutionary conserved 
events, called the ‘cell cycle’. Aberrations in the cell cycle have severe implications and can 
cause cancerous growth. A detailed understanding of the cell cycle and its regulation may 
identify additional targets for cancer therapy (1-3). The cell cycle has been the subject of 
previous proteomics studies. Olsen et al. (4) measured the dynamics of thousands of proteins 
and phosphorylation events across cell cycle phases of HeLa cells, providing insights into the 
underlying regulatory mechanisms and pointing to a general increase in phosphorylation site 
occupancy during M phase. In a targeted study, Pagliuca et al. (5) investigated interactors of 
cyclins E1, A2 and B1 in HeLa cells, revealing key mechanistic links between DNA replication 
and mitosis.  
 
55 
 
Schizosaccharomyces pombe (fission yeast) is a unicellular organism, which can be easily 
genetically manipulated and carries many cell cycle features similar to metazoan cells. It is an 
important model organism to study the cell cycle and its checkpoint controls (6). Recent global 
proteomics studies of yeasts and their cell cycle (7-13) have mainly focused on 
Saccharomyces cerevisiae (budding yeast), with only few studies of fission yeast (14, 15), 
although the fission yeast cell cycle may be more representative of eukaryotic cell cycles (16). 
However, attention of the proteomics community towards S. pombe is increasing. Recent 
proteomics studies covered up to 4,087 S. pombe proteins (71 % of the predicted proteome) 
and 1,544 phosphoproteins in both asynchronous and synchronized cell cultures (17-22); 
however, a comprehensive analysis of the S. pombe cell cycle is so far missing.  
 
Here we use high-resolution mass spectrometry in combination with a stable isotope labeling 
by amino acids in cell culture (SILAC) method, termed super-SILAC (23), and intensity-based 
absolute quantification (iBAQ) (24) to measure relative and absolute dynamics of the proteome 
and phosphoproteome during the cell cycle of fission yeast. We estimate copy numbers for 
3,178 S. pombe proteins and combine these data with calculated phosphorylation site 
stoichiometry to estimate the total amount of protein-bound phosphate and its dynamics across 
the cell cycle. Providing the global absolute dynamics and stoichiometry of proteins and their 
modifications will be a valuable resource for classical and systems biologists alike.  
 
3.3 Materials and methods 
Overview of the experimental design 
SILAC-labeled cells were synchronized using the temperature sensitive cdc25-22 allele (25). 
Briefly, cells were grown at 25°C (permissive temperature) to a cell density of 6-7 x 106 cells/mL 
and arrested at late G2 phase by shifting to 36°C (restrictive temperature) for 5 hrs. Cells were 
released into the cell cycle by shifting the temperature back to 25°C. The Lys0-labeled cells 
were harvested at 17 min (M phase) and 32 min (G1 phase), whereas the Lys8-labeled cells 
were harvested at 0 min (G2 phase; without shifting back to 25 ºC) and 50 min (S phase). To 
perform relative quantification of the four cell cycle phases we generated a super-SILAC 
standard (26) by mixing an equal number of cells from the G2, M, G1 and S phases labeled 
with medium-heavy lysine (Lys4). We added this standard to equal numbers of cells from M 
(Lys0) and S (Lys8); and, separately, from G1 (Lys0) and G2 (Lys8), resulting in two triple-
SILAC samples (Figure 1). Each sample was digested with endoproteinase Lys-C followed by 
fractionation via isoelectric focusing (Off-Gel) and strong anion exchange chromatography 
(SAX). Phosphopeptides were enriched using SCX followed by TiO2 chromatography. The 
resulting fractions were measured on Orbitrap Elite and Orbitrap XL mass spectrometers and 
quantified by MaxQuant software at the proteome and phosphoproteome level. 
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Figure 1. Relative and absolute dynamics of the proteome and phosphoproteome during four phases 
of the fission yeast cell cycle. Four separate cell cultures of S. pombe representing the cell cycle 
phases and four separate cell cultures for the super-SILAC standard were labeled using SILAC 
media containing either Lys0, Lys4 or Lys8. The cultures were arrested in late G2 phase using the 
temperature-sensitive cdc25-22 allele. Reduction to permissive temperature allowed the cells to 
synchronously enter mitosis and synchronously continue the cell cycle. The G2 phase sample was 
collected by harvesting the cells after 5 hr of incubation at 36°C. Samples of M, G1 and S phase 
were collected 17 min, 32 min and 50 min after release to 25 ºC, respectively. M phase (Lys0) and 
S phase (Lys8) were mixed with the super-SILAC (Lys4) experiment before protein digestion, as 
were G1 phase (Lys0) and G2 phase (Lys8). Cells were mixed in a 1:1:1 ratio based on cell count. 
The two experiments were digested with Lys-C and either fractionated at the peptide level (Off-Gel 
or SAX) or enriched for phosphopeptides using SCX followed by TiO2 enrichment. All samples were 
measured using LC-MS/MS. 
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S. pombe strains 
We used SM205 h+ lys1 leu1-32::ura4+ plo1+-mCherry<<natR ura4::EGFP-pcn1+ cdc25-22 
and SM222 h+ uds1-GFP:kanMX6 leu1 plo1+-mCherry<<natR cdc25-22. 
 
SILAC 
The amino acid derivatives 4,4,5,5-D4-L-lysine (Lys4, “medium-heavy lysine”, K4) and 
13C615N2-L-lysine (Lys8, “heavy lysine”, K8) (both: Cambridge Isotope Laboratories) were used. 
Cells were cultured in K4 or K8 containing minimal medium for approximately 8-10 cell cycles 
in order to ensure sufficient incorporation of the labeled amino acids into proteins. 
 
Cell harvesting 
We harvested 1.26 x 109 cells at each cell cycle phase. Cells were pelleted by centrifugation 
(3000 g, 2 min, centrifuge at 40°C for G2 samples, or 4 ºC for samples from other phases). All 
tubes and reagents were kept at 37 ºC for G2 samples and at 4 ºC for samples from other 
phases. After washing with H2O and decanting of the supernatant, a small amount of residual 
liquid remained, in which cells were resuspended. The cell suspension was dripped into liquid 
nitrogen (lN2) so that cells were shock-frozen immediately. Residuals of the cell suspension 
were taken up in 1 mL cold methanol (-20°C) for microscopic analysis. The cell pellets resulting 
from freezing in lN2 were stored at -80°C until protein extraction was performed. At the same 
time as harvesting, cells from 10 mL cell culture were pelleted to prepare a TCA (trichloroacetic 
acid) protein extract that was analyzed by immunoblotting.  
 
Cell disruption and protein extraction 
For large-scale preparation of fission yeast protein extracts, cell disruption was performed 
using a ball mill grinder (Mixer Mill MM 400, Retsch) under cryogenic conditions. Frozen cell 
droplets of light (K0) G1 sample and heavy (K8) labeled G2 sample, as well as cell droplets 
from light (K0) M sample and heavy (K8) labeled S phase sample were mixed according to 
their cell number in a 1:1 ratio. For the SILAC standard, cell droplets from medium (K4) labeled 
G2, M, G1 and S phase samples were mixed according to their cell number in a 1:1:1:1 ratio. 
Droplets were filled into a lN2-cooled 50 mL metal bucket with 1 metal ball (Ø 25 mm) and 
subjected to 5 ball mill runs (3 min at frequency 30/sec) with cooling in lN2 between runs. The 
resulting powder was stored at -80°C. The cell powder was resuspended in denaturation buffer 
(6 M urea, 2 M thiourea, 1 % (w/v) n-octylglucoside (Roche), 10 mM Tris pH 8.0) to a final 
protein concentration of approximately 10 mg/mL. The suspension was incubated for about 1 
hr at 4°C while shaking before insoluble material was removed twice by centrifugation (7197 
g, 10 min, 4°C). The supernatant was aliquoted and stored at -80°C. This procedure yielded 
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approximately 130 mg and 60 mg of protein for the SILAC standard and M/S – G1/G2 samples 
respectively.  
 
Microscopy 
Methanol-fixed cells were washed with PEM/methanol ((100 mM PIPES, 1 mM EGTA, 1 mM 
MgSO4; pH 6.8 with KOH)/50 % methanol) and with PEM. For DNA staining, cells were 
resuspended in 100 μL PEM containing 2 µg/mL DAPI (Sigma) and incubated at room 
temperature for at least 10 min. Cells were pelleted and 4 μL of the pellet were mounted. 
Images were acquired on an Axio Imager.M1 microscope (Zeiss) with a Plan-Apochromat 
63x/1.4 oil objective (Zeiss) driven by a Piezo Z motor. Images were recorded with a charged-
coupled device camera (CoolSnap EZ, Roper) and processed using the software MetaMorph 
7.6.0.0 (Molecular Devices). 14 individual planes spaced by 0.3 μm were acquired. In order to 
create color-combined pictures, out-of focus planes were removed, 10 sections of each the 
GFP and mCherry channels were projected (maximum intensity projection), and signal 
intensity was adjusted for all pictures in a similar way. For the DAPI channel, only one of the 
in-focus planes was chosen for the color combined picture.  
 
Immunoblots 
Proteins were separated by SDS-PAGE and transferred onto PVDF membranes (Immobilon-
P, Millipore) using a semi-dry transfer system (Amersham). Primary antibodies are listed in 
Supplementary Table 1. Horseradish peroxidase (HRP)-coupled secondary antibodies were 
detected by chemiluminescence.  
 
Trichloroacetic acid extraction 
4 x 107 cells were harvested by centrifugation (3000 g, 1 min, RT) and resuspended in 1 mL 
cold 20 % (v/v) TCA. Cells were pelleted by centrifugation (775 g, 2 min, RT). The supernatant 
was removed and cells were washed with 1 mL 1 M Tris and pelleted again. The cell pellet 
was resuspended in 100 – 200 μL 2x SDS sample buffer (125 mM Tris pH 6.8, 4 % (w/v) SDS, 
20 % glycerol, 200 mM DTT, 0.02 % (w/v) bromophenol blue) and boiled at 95°C for 10 min. 
600 μL glass beads (500 μm) were added and the samples were vortexed strongly 
(FastPrep™120 BIO101, Thermo Electron Corporation; 3 x 40 sec, level 5, with a 3 min break 
in between the individual runs). A hole was made in the bottom of the tube with a needle and 
the cell extract was eluted in a new reaction tube by centrifugation (60 sec, 956 g, 4°C) thereby 
separating the extract from the glass beads. The resulting samples were boiled again at 95°C 
for 10 min and centrifuged (16000 g, 10 min, RT) in order to pellet the cell debris.  
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Intracellular ATP quantification 
Cells were disrupted using a ball mill grinder (Mixer Mill MM 400, Retsch). ATP was extracted 
using 5 % (v/v) TCA and measured using the ENLITEN Kit (Promega) according to the 
manufacturer's instructions. After ATP extraction, samples were neutralized with 20 mM 
sodium acetate buffer and diluted 50-fold and 1000-fold with ATP-free water. The luciferase 
reagent was added and luminescence was recorded for 10 s after a 2.5 s wait. A standard 
curve, using ATP included in the kit, was used to transform relative luminescence units (RLU) 
into ATP concentration. The amount of cells measured in each sample was used to calculate 
ATP molecules per cell. Because the cdc25-22-synchronized cells have a cell volume that is 
3.51-times larger than unsynchronized cells (27), the resulting value was divided by 3.51.  
 
In-solution digestion 
The SILAC standard was added to the G1/G2 and M/S samples before digestion. For absolute 
quantification, the Proteomics Dynamic Range Standard set (UPS2, Sigma-Aldrich) was 
spiked in before protein in-solution digestion (24). 8 mg of protein extract dissolved in 
denaturation buffer (6 M urea, 2 M thiourea, 1 % (w/v) n-octylglucoside (Roche) were digested 
in-solution (28). Briefly, proteins were reduced with 1 mM dithiothreitol, alkylated with 5.5 mM 
iodoacetamide, digested at RT for 3 hr with 1:100 (w/w) endoproteinase Lys-C (high urea 
concentration). Sample was diluted with 4 volumes of water before digestion over night at RT 
with 1:100 (w/w) endoproteinase Lys-C or 1:100 (w/w) Trypsin (low urea concentration). The 
protein digest was acidified using TFA to a final concentration of 0.1 % (v/v) to stop the protein 
digestion. In the case of samples fractionated using the Off-Gel fractionation no TFA was 
added. 
 
Lysine Acetylation Enrichment 
Lysine-acetylated peptides were enriched by immunoprecipitation using anti-AcK antibodies 
as described before with some modifications (29). Peptides were desalted using solid phase 
extraction before being dissolved in IP buffer (50 mM MOPS pH 7.2, 10 mM Sodium phosphate 
and 50 mM Sodium chloride). Peptides were incubated with agarose conjugated anti-
acetyllysine antibody (Immunechem) overnight at 4°C on a rotation wheel. The 
immunoprecipitates were washed four times with IP buffer and two times with water before 
being eluted three times with 0.1% TFA in water. The eluted peptides were purified using 
Stage-Tips (30). 
 
Phosphopeptide enrichment 
After protein digestion, 7.5 mg of the samples was enriched for phosphopeptides using strong 
cation exchange chromatography (SCX) followed by TiO2 chromatography as described before 
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(31) with minor modifications. Samples were injected using SCX Buffer A (5 mM KH2PO4, 30% 
acetonitrile (ACN), pH 2.7) and separated with a gradient from 0 to 35 % of SCX Buffer B (350 
mM KCl, 5 mM KH2PO4, 30% ACN, pH 2.7). The resulting 15 fractions and phosphopeptides 
from the flow-through (FT) were further enriched by TiO2 chromatography. Three consecutive 
rounds of enrichment were performed with the FT. The resulting 18 samples were eluted three 
times with 40 % ammonium hydroxide solution in ACN with pH 10.5. After elution, samples 
were evaporated to a final volume of 5 µL and injected into the LC-MS system.  
 
Off-Gel fractionation 
100 µg of protein digest were fractionated by isoelectric focusing using the OFFGEL 3100 
Fractionator (Agilent) according to the manufacturer’s instructions (32). Separation was 
performed on a 13 cm Immobiline DryStrip (GE Healthcare) at a maximum of 50 µA for 20 kVh. 
The peptide fractions were purified using Stage-Tips (33). 
 
Strong anion exchange chromatography (SAX) 
50 µg of protein digest were fractionated using strong anion exchange chromatography (SAX) 
(34). Briefly, digested proteins were desalted using solid phase extraction (SPE), mixed 1:1 
with Britton & Robinson Universal Buffer at pH 11 (0.02 M CH3COOH, 0.02 M H3PO4 and 0.02 
M H3BO3) and loaded onto a Stage-Tip based anion exchange column containing six layers of 
Empore Anion Exchange (Varian). The flow through was collected and desalted using a Stage-
Tip. Peptides were then eluted with Britton & Robinson Universal Buffer at pH 8, 6, 5, 4 and 3 
and desalted using Stage-Tips.  
 
NanoLC-MS/MS 
An EASY-nLC II system (Proxeon Biosystems) coupled to an LTQ Orbitrap XL, an LTQ 
Orbitrap Velos or an LTQ Orbitrap Elite (Thermo) was used for the LC-MS/MS measurements. 
Peptides were separated on a 15 cm PicoTip fused silica emitter ID 75 µm (New Objective) 
packed in-house using reversed-phase beads ReproSil-Pur C18-AQ 3 µm (Dr. Maisch GmbH). 
Peptides were injected with Solvent A (0.5 % acetic acid) at a maximum pressure of 280 bar 
using the IntelliFlow option and separated at 200 nL/min. Separation was performed using a 
linear 106 min gradient of 5-33 % solvent B (80 % ACN in 0.5 % acetic acid) for phosphopeptide 
samples and either an 81 or a 221 min segmented 5-50 % solvent B gradient for all other 
samples. 
 
For proteome samples, an LTQ Orbitrap Velos and an LTQ Orbitrap Elite were operated in 
positive mode. Precursor ions were recorded in the orbitrap analyzer at a resolution of 60,000 
(LTQ Orbitrap Velos) or 120,000 (LTQ Orbitrap Elite) followed by MS/MS spectra acquired in 
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the LTQ mass analyzer. Data-dependent analysis was used and either the 15 (LTQ Orbitrap 
Velos) or the 20 (LTQ Orbitrap Elite) most abundant precursor ions from the full scan were 
fragmented using collision-induced dissociation (CID). Fragmented masses were excluded for 
90 s. The target values were 1E6 charges for the MS scans in the Orbitrap and 5,000 charges 
for the MS/MS scans in the LTQ with a maximum fill time of 100 ms and 25 ms respectively.  
 
Phosphoproteome samples were measured using an LTQ Orbitrap XL with the same 
parameters as for the proteome samples with the following changes: precursor ions were 
recorded at 60,000; the 5 most abundant precursor ions were fragmented by activation of the 
neutral loss ions at -98, -49 and -32.6 Thompson relative to the precursor ion (35); the 
maximum fill time was 150 ms for MS and 1000 ms for MS/MS scans.  
 
Data processing and analysis 
MS raw files were processed using MaxQuant software (v.1.2.2.9) (36). Multiplicity was set to 
three, matching the number of SILAC labels used (‘light’, ‘medium’, ‘heavy’) in each 
experiment; Lys4 and Lys8 were specified as ‘medium’ and ‘heavy’ labels, respectively. 
Database search was performed after peptide quantification using the Andromeda search 
engine (37), which is part of MaxQuant. Full enzyme specificity was required and up to two 
missed cleavages were allowed. For proteome and phosphoproteome measurements, Lys-C 
was specified as the enzyme used, for lysine acetylation-enriched samples, trypsin was 
specified as the enzyme used. The MS/MS spectra were searched against a target database 
consisting of 5,075 entries from the S. pombe proteome database (http://www.pombase.org/, 
Protein Dataset in FASTA format, downloaded on April 6th, 2011), 50 entries from the 
Proteomics Dynamic Range Standard (UPS2, Sigma), the mCherry protein sequence, the 
EGFP protein sequence, and 248 frequently seen laboratory contaminants. To control the false 
discovery rate of database search results, the software appends a corresponding decoy 
version of the target database resulting in a total of 10,750 database entries. 
Carbamidomethylation on cysteines was defined as fixed modification, oxidation of methionine 
and protein N-terminal acetylation were set as variable modifications; initial mass tolerance for 
the precursor ion was set to 6 ppm and fragment ion mass tolerance for CID fragmentation 
data was set to 0.5 Da; for HCD fragmentation data fragment ion mass tolerance was set to 
20 ppm. In addition, we included phosphorylation of serine, threonine and tyrosine (STY) and 
acetylation of lysine as variable modifications for the data derived from samples enriched for 
phosphopeptides and lysine-acetylated peptides, respectively. Database search results were 
further processed for statistical validation and identified MS/MS spectra were assembled into 
peptides, protein groups and modification sites at a default false discovery rate (FDR) of 1 % 
at all levels. The estimated FDR after database search was 1 % at the protein group level, 0.97 
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% at the phosphorylation site level and 0.54 % at the peptide level (S. pombe and UPS 
proteins). A list containing S. pombe peptide and UPS sequences detected at an estimated 
FDR of 0.54 % without reverse hits and without contaminants can be found in Supplementary 
Table 2. For protein quantification, a minimum of two quantitation events was required. Peptide 
evidences of single-peptide-based protein identifications are listed in Supplementary Table 
3. 
 
Relative quantification 
The two triple SILAC experiments were combined to get a ratio profile for each protein and 
phosphorylation event across the four cell cycle phases relative to the Lys4-labeled super-
SILAC standard. Ratios of proteins and phosphorylation events were transformed to log2 scale 
and only proteins and phosphorylation events (P-events) that were quantified in all four phases 
were considered for further quantitative analysis. The magnitude of fluctuation was expressed 
by calculating the standard deviation of the log-transformed ratios across the four phases. The 
quartiles of the distribution resulting from all quantified features were determined and used to 
separately bin proteins and P-events according to the extent of fluctuation across the cell cycle 
phases. Those belonging to the quartile with the highest standard deviation (75-100 %) were 
defined as “fluctuating” or dynamic, whereas those belonging to the quartile with the lowest 
standard deviation (0-25 %) were defined as “non-fluctuating” or static. 
 
Absolute protein quantification 
We used the iBAQ approach for absolute protein quantification, which calculated absolute 
protein amounts proportional to the molar amounts of a spiked-in protein standard consisting 
of 48 proteins (UPS2, Sigma). The method is natively supported by the MaxQuant software 
and was operated using standard parameters (log-fit option). Resulting iBAQ values were 
subsequently adjusted according to the amount of UPS2 protein that was spiked in to one of 
the measured samples (M and S cell cycle phases, Off-Gel proteome measurement). The total 
number of cells in the sample (Ncells) was used to calculate the absolute protein copy numbers 
(CNprotein) by applying the following formula: 
 
𝐶𝑁𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =
𝑁𝐴(𝑖𝐵𝐴𝑄𝑝𝑟𝑜𝑡𝑒𝑖𝑛 ∗ 10
−15)
𝑁𝑐𝑒𝑙𝑙𝑠
 
 
with 𝑁𝐴 being the Avogadro constant. Because the cdc25-22-synchronized cells have a cell 
volume that is 3.51-times larger than unsynchronized cells (27), the resulting values were 
divided by 3.51 to obtain the copy number in a typical unsynchronized cell. This assumes that 
protein concentration is similar between cdc25+ and cdc25-22 cells, which is not formally 
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known. The absolute protein amounts calculated for the super-SILAC standard together with 
corresponding SILAC ratios were used to calculate the absolute amount for each protein in the 
four cell cycle phases.  
 
Absolute phosphorylation site occupancy 
The proportion between the phosphorylated and nonphosphorylated version of the same 
peptide defines the occupancy of the corresponding phosphorylation site. Olsen et al. (4) 
described a model to calculate the occupancy of singly phosphorylated peptides by using the 
SILAC ratios of (1) the phosphorylated peptide, (2) the nonphosphorylated peptide, and (3) the 
corresponding protein, assuming that all three ratios are measured accurately, that the ratios 
change between the different states, and that there are only two versions of the peptide 
(nonphosphorylated and phosphorylated on a single site). For details on the calculation see 
Olsen et al. (4). We calculated occupancy values separately for the two replicates of our 
dataset using an in-house developed perl-script. The SILAC ratios of phosphorylated peptides 
were derived from the corresponding SCX fractions, whereas for nonphosphorylated peptides 
and proteins we used the SILAC ratios measured in the proteome measurements (Off-Gel). 
 
Absolute phosphate stoichiometry 
We calculated the absolute phosphate stoichiometry as product of site occupancy and protein 
copy number of the protein carrying the phosphorylation site. This calculation was done only 
when both values for a specific phase were available (101 sites in G2 phase, 71 in sites M 
phase, 81 in G1 phase, 67 in S phase). In order to estimate the global level of protein bound 
phosphate, we first inferred estimates of median occupancy and standard deviation by 
performing 10,000 bootstrap iterations on the available occupancy values in each cell cycle 
phase. We then imputed missing occupancy values by sampling from a normal distribution 
using the bootstrap estimates as parameters for mean and standard deviation and calculated 
absolute phosphate stoichiometry as described above. We calculated bootstrap confidence 
intervals (CI) for the median occupancy using the 0.025 and 0.975 percentiles of the bootstrap 
distribution resulting in a 95 % CI. 
 
Peak time index calculation 
We performed the analysis on expression peak time indices of proteins and phosphorylation 
sites as described in (4). Briefly, the SILAC ratios for each item (i.e. protein or P-event) were 
normalized to the maximal change across the four cell cycle phases. For each item we 
calculated the weighted mean of the expression ratio at the phase with maximal change with 
respect to the normalized ratios of adjacent phases. To assign the resulting ‘peak time index’ 
of every item to a specific cell cycle phase, we applied hierarchical clustering on these values 
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using the Euclidian distance and a defined cluster number corresponding to the four cell cycle 
phases addressed in this study. 
 
Functional enrichment analysis 
We retrieved Gene Ontology (GO) annotation of S. pombe from GeneDB (downloaded on 
December 6th, 2011). To test whether specific annotation terms are enriched or depleted within 
a set of proteins of interest we applied Fisher’s exact test using the theoretical S. pombe 
proteome as background. Derived p-values were further adjusted to address multiple 
hypothesis testing using the method proposed by (38). 
 
3.4 Results 
We measured relative and absolute dynamics of the proteome and phosphoproteome during 
the four major phases of the cell cycle – G2, M, G1 and S – using highly synchronized S. 
pombe cultures and SILAC (Figure 1; Supplementary Figure 1). To relatively quantify all four 
cell cycle phases we generated a super-SILAC standard (26), consisting of a mixture of cells  
from all four phases. The standard was combined with two of the cell cycle phase-specific 
samples (either G1 and G2, or M and S) to yield a triple-SILAC sample. The quantitative 
information from both triple-SILAC measurements was integrated through this common 
standard to obtain the relative dynamics of the proteome and phosphoproteome across the 
cell cycle (Figure 2A). Fluorescence microscopy confirmed more than 90 % synchronicity for 
all analyzed cell cycle phases, and characteristic changes were verified by immunoblotting 
(Figure 2B and C; Supplementary Figure 1). In 137 LC-MS runs, we recorded 2,471,241 
MS/MS spectra that identified a total of 32,016 non-redundant peptides from 3,753 S. pombe 
proteins at estimated false discovery rates (FDR) of 0.53 % at the peptide and 0.99 % at the 
protein level. The identified proteins accounted for 74 % of the predicted S. pombe proteome  
 (5,075 proteins). In the phosphoproteome measurement we identified 3,682 phosphorylation 
events (on 1,554 proteins) of which 2,465 were localized to a specific Ser/Thr/Tyr residue 
(Supplementary Table 4). The identified and quantified proteins as well as phosphorylation 
events are presented in Supplementary Table 5 and 6. Additionally, we detected 328 
acetylation events on 184 proteins (including histones, cohesin, SAGA subunits, ribosomal 
proteins and metabolic enzymes; Supplementary Table 7), which were not analyzed further 
due to technical bias towards highly abundant proteins as a result of low enrichment efficiency 
(not shown).  
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Relative quantification of proteome and phosphoproteome dynamics 
Application of the super-SILAC approach enabled relative quantification of 2,416 proteins and 
1,963 phosphorylation events across all analyzed phases of the cell cycle. We achieved high 
reproducibility between the spiked-in super-SILAC standard of each triple SILAC sample (0.9 
≤ r ≤ 0.93) (Supplementary Figure 2). Changes on the protein level were minimal (Figure 
3A), which lead to a relatively low correlation of protein ratios (0.26 ≤ r ≤ 0.62) (Supplementary 
Figure 3A). In contrast, changes at the phosphoproteome level were considerably more 
pronounced (Figure 3B) and showed high reproducibility between both replicates (0.7 ≤ r ≤ 
0.82) (Supplementary Figure 3B). Normalization of phosphorylation site abundance to the 
protein level resulted in negligible differences (Supplementary Figure 3C-D), so that we 
analyzed phosphorylation data without protein normalization. We validated our data by 
performing immunoblots and fluorescence microscopy to measure dynamics of selected 
positive controls, which were overall in agreement with the MS data (Supplementary Figures 
4 and 5).  
 
 
Figure 2. Data integration and synchronicity for all analyzed cell cycle phases. (A) The samples are 
compared to each other using a super-SILAC standard (STD) containing a mixture of G2, M, G1 
and S phases. By comparing the information of these two experiments through the common 
standard, a profile for each quantified protein and phosphorylation event is obtained. (B) 
Synchronization of the cells was confirmed by fluorescence microscopy using Plo1-mCherry (M 
phase) and EGFP-PCNA (S phase) as markers. A synchronicity of more than 90 % was achieved 
in the samples used for G1/G2 and the M/S samples (Supplementary Fig. 1). (C) Immunoblot 
analysis of known cell cycle-dependent proteins or phosphorylation events in the standard and 
experimental samples. MPM2 is an antibody generated against mitosis-specific phosphoepitopes 
(Supplementary Table 1). 
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Figure 3. Dynamics of proteins and phosphorylation events across the cell cycle phases. Diagrams for 
each quantified (A) protein and (B) phosphorylation event relative to the super-SILAC standard 
plotted against its intensity recorded in the mass spectrometer. Red dots indicate statistically 
significant (p < 0.01) outliers from the distribution. The boxplots below the figures depict the 
distribution of SILAC ratios described above. Boxplot diagrams of standard deviations (SD) 
calculated from SILAC ratios across the four phases of the cell cycle for (C) proteins and (D) 
phosphorylation events; dashed lines represent the quartiles of SDs based on the whole dataset; 
these were used to group proteins and phosphorylation events according to their extent of 
fluctuation across the cell cycle; the upper quartile (>75%) was used to define fluctuating proteins 
and phosphorylation events (see methods). Overlap of (E) fluctuating proteins or (F) fluctuating 
phosphorylation events between the replicates and boxplot of correlation coefficients between the 
profiles of fluctuating proteins or phosphorylation events. 
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To assess the extent of fluctuation of proteins and phosphorylation events across the cell cycle, 
we used the standard deviation of log-transformed SILAC ratios across the different cell cycle 
phases and binned the proteins and phosphorylation events into quartiles of the resulting 
distribution (Figure 3C-D). Proteins or phosphorylation events with the highest standard 
deviation were defined as fluctuating. This analysis confirmed that strong fluctuation 
predominantly occurred at the phosphoproteome level (1,032 fluctuating events, 
Supplementary Table 8), whereas protein abundance during the cell cycle was much more 
static (only 54 fluctuating proteins were detected, Supplementary Table 9). Of these 1,032 
fluctuating phosphorylation events and 54 proteins, 638 events and 37 proteins were quantified 
across all four analyzed cell cycle phases in the replicate analysis. From this overlap, 591 
phosphorylation events were fluctuating in both replicates and showed high correlation in the 
relative expression across the four cell cycle phases (median correlation coefficient: 0.99). A 
lower number of proteins (10) was fluctuating in both replicates and had lower correlation 
(median correlation coefficient: 0.41), likely as a consequence of the lower extent of protein 
fluctuation (Figure 3E-F). Relative expression of fluctuating proteins and phosphorylation 
events can be found in Supplementary Data File I and II. Due to high correlation, especially 
of fluctuating phosphorylation events, we concluded that each of the replicates is 
representative of the whole dataset and therefore we proceeded with one replicate for further 
analysis. 
 
Functional classes of fluctuating proteins and phosphorylation events 
The strongest fluctuating protein that was identified in all four phases was the cyclin B Cdc13 
(high in G2 and M, low in G1 and S, Supplementary Table 9), whose degradation at the 
transition from M to G1 is well known (39) (Figure 2C). Strongly fluctuating was also the 
septation protein Uds1 (highest in S). This had been observed by MS previously (40) and we 
confirmed by immunoblotting and fluorescence microscopy (Figure 2C, Supplementary 
Figure 4 and 5). On the phosphoproteome level, we recovered the well-known cell cycle-
regulated phosphorylation of histone H3-Ser10 (41) (Figure 2C) as well as several previously 
known cell cycle-specific phosphorylations, including mitosis-specific phosphorylation of 
monopolin Mde4 (42), survivin Bir1 (43) and previously identified sites phosphorylated by 
Aurora kinase (17). Interestingly, we observed considerable cell cycle-specific fluctuation in 
the phosphorylation of nucleoporins, which mimics observation in human cells (44), despite 
the fact that fission yeast, unlike human cells, undergoes a closed mitosis (Figure 4A; 
Supplementary Table 8).  
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We performed functional enrichment analysis for the proteome and the phosphorylation data 
separately for the different quartiles (Supplementary Figures 6A-B). As expected, cell cycle-
related domains and processes such as regulation of cyclin−dependent protein kinase activity 
and septum were overrepresented among the fluctuating proteins. Housekeeping processes 
like the TCA, citric acid and urea cycles, glycolysis, ribosome and translation were 
overrepresented among non-fluctuating proteins. At the phosphorylation level, cell cycle 
cytokinesis, mitotic cell cycle spindle assembly checkpoint, spindle assembly and regulation of 
transcription during mitosis were overrepresented, whereas translation and mitochondrial 
translation were among the underrepresented functional classes. Our global analysis also 
indicated which kinases have a large influence on cell-cycle dependent fluctuations (CDK1, 
CDK2, Polo kinase), and which kinases act mostly in a cell-cycle independent fashion (CK1, 
CK2) (Supplementary Figure 6C).  
 
Figure 4.  Selected cell cycle dependent phosphorylation events and sorting of protein and 
phosphorylation variation according to peak time index. (A) Cell cycle dependent variation in 
the phosphorylation of nuclear pore or nuclear membrane related proteins, (B) inorganic phosphate 
transporters, or (C) phosphate metabolism enzymes. Each circle represents a phosphorylation 
event detected on the respective protein and colored according to the cell cycle phase with the 
highest phosphorylation; circles with a P represent phosphate. (D) Proteins or (E) phosphorylation 
events within the quartile of highest fluctuation were clustered in the cell cycle phases according to 
their peak time index (see methods). Protein and phosphorylation events in this figure can be found 
and are highlighted in Supplementary Tables 8 and 9. 
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For each of the fluctuating proteins or phosphorylation events, we determined the cell cycle 
phase with the highest value and used the peak time indices (4) as similarity measure for 
hierarchical cluster analysis. The resulting four clusters contained the proteins and 
phosphorylation events that were most prominent in each analyzed cell cycle phase (Figure 
4D-E). Functional enrichment analysis of proteins and phosphorylation events in the resulting 
phase-specific clusters revealed that kinase-related functions increased specifically in the G2 
phase. Furthermore, several mitosis-related biological processes were increased during 
mitosis, further validating our approach (Supplementary Figure 6D-E). 
 
Using the measured SILAC ratios of phosphoproteins, phosphopeptides and their unmodified 
counterparts, we calculated stoichiometry (occupancy) of 101 phosphorylation sites in G2 
phase, 71 sites in M phase, 82 sites in G1 phase and 67 sites in S phase. In agreement with 
previous studies (4), the highest median occupancy of 44.2 % was measured in M phase. 
Average occupancy was reduced in the subsequent phases reaching a minimum of 23 % in 
G2 phase (Figure 5). 
 
 
Figure 5. Phosphorylation site stoichiometry. (A) Boxplots of phosphorylation site stoichiometry 
calculations for each cell cycle phase (see methods). The number of phosphorylation sites is shown 
at the top of the figure, while the numbers in the boxes represent the median values of all calculated 
phosphorylation site occupancies. (B) Cumulative diagram of the phosphorylation site occupancy in 
the studied cell cycle phases. 
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Absolute quantification  
We estimated absolute levels of S. pombe proteins using the iBAQ approach (24). This method 
correlates the MS signal intensities and the number of observable peptides of each protein to 
a spiked-in protein standard. We spiked 48 proteins from 0.5 fmol to 50,000 fmol into one 
fraction of our measurements (Off-Gel fractions of M and S phase triple SILAC measurement) 
and detected 23 of the spiked-in proteins at concentrations between 50 fmol and 50,000 fmol. 
This pointed to an underrepresentation of very low abundant proteins. The detected standard 
proteins enabled the calculation of iBAQ values for 3,178 S. pombe proteins (Supplementary 
Figure 7A).  
 
The dynamic range of protein copy numbers spanned almost five orders of magnitude, which 
was in agreement to the dynamic range determined in asynchronously growing S. pombe cells 
(18, 22) (Figure 6A, Supplementary Table 10, Supplementary Figure 8). The total number 
of protein molecules in an average S. pombe cell was 176 million, with single proteins having 
between 92 (Snf59) and 1.4 million (enolase) copies. Eighty percent of the whole protein 
content was constituted by twenty percent of the most abundant proteins, consistent with the 
Pareto 80-20 principle, also observed by Marguerat et al. (18) (Figure 6B).  
 
We compared our absolute quantification to several studies that used different technologies to 
derive absolute protein amounts in S. pombe: MS-intensity based absolute quantification (18, 
19, 22), and fluorescence microscopy-based quantitation (27, 45). It has been reported that 
cdc25-22 cells under the used growth conditions are 3.51 fold larger, which was taken into 
account when normalizing the protein copy numbers (see methods) (27). Overall, we found a 
good correlation of protein copy numbers compared to previous studies (Pearson-correlation 
> 0.7 Supplementary Figure 7B-F). Our numbers were higher when compared with 
Gunaratne et al. (19), however they were in agreement with the other four studies used for 
comparison (18, 22, 27, 45). The stoichiometry of several known stable protein complexes was 
also compared and subunit stoichiometry was in agreement with previous studies (Table I). All 
studies dealing with estimation of absolute protein numbers are exposed to multiple sources 
of error (see Discussion) and all absolute numbers (from our and others’ studies alike) should 
therefore be treated as estimates. 
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Estimation of the absolute amount of protein bound phosphate groups 
The availability of phosphorylation site occupancies and absolute protein copy numbers 
enabled us to address the absolute amount of Ser/Thr/Tyr phosphorylation in the different 
phases of the cell cycle. In order to estimate the absolute level of protein-bound phosphate we 
imputed missing occupancy values by bootstrapping (see methods) and calculated the number 
of protein-bound phosphate for all proteins that we absolutely quantified. Our results showed 
that the total number of protein-bound phosphate groups fluctuates between 0.056 and 0.106 
fmol or between 34 million (G2 phase) and 64 million phosphate groups (M phase). The 
cumulative distribution of the estimated number of protein-bound phosphate groups had a very 
similar distribution to the cumulative distribution of the protein copy numbers and both followed 
the 80/20 Pareto principle. (Figure 6C, Supplementary Figure 9).  
 
In order to assess the amount of ATP required for protein phosphorylation during the G2/M 
transition we measured the intracellular amount of ATP in asynchronous cells. We then used 
this information to address the absolute consumption of ATP needed for protein 
phosphorylation across the cell cycle. We measured the amount of ATP to be 217 ± 14 amol 
per cell, which is in agreement with values reported before (46, 47). The amount of ATP 
required for protein STY phosphorylation during the G2/M transition is 30 million phosphate 
molecules (50 amol), which corresponds to 23 % of the average amount of ATP in 
asynchronous cells. Hence, a significant amount of ATP is needed to phosphorylate proteins 
required to drive the cell cycle through the G2/M transition. Consistently, we observe 
phosphorylation (and hence presumably regulation) of phosphate transporters and enzymes 
of phosphate metabolism during mitosis (Figure 4B-C, Supplementary Table 6 and 9).  
 
 
Figure 6. Absolute quantification. (A) Histogram of the protein copy number in log10 from the super-SILAC 
standard with dashed lines indicating the quartiles. (B) Cumulative diagram of protein copy number 
in each cell cycle phase. (C) Cumulative diagram of absolute protein-bound phosphate groups in 
each cell cycle phase (see methods).  
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3.5 Discussion 
The cell cycle is a complex dynamic process involving multiple layers of regulation and its 
global analysis is challenging. The super-SILAC approach combined with high accuracy mass 
spectrometry is a powerful tool that enables integrative analysis of several samples by 
comparing them to a common standard. Super-SILAC was used previously to analyze specific 
proteomes of various cell lines (48), cancer cell lines (26) and mouse tissues (49). Here we 
applied it to measure relative dynamics of the proteome and phosphoproteome during the four 
major phases of the cell cycle (G1, S, G2 and M) in fission yeast. A similar approach was used 
by Olsen et al. to quantify phosphoproteome/proteome dynamics of HeLa cells, albeit using 
unsynchronized cells instead of an equal mixture of labeled synchronized cells as internal 
standard (4). The 3,753 proteins identified in our study represent 74 % of the predicted fission 
yeast proteins, making it one of the most comprehensive published protein dataset of this 
organism to date. To enable triple-SILAC labeling and avoid quantification problems arising 
from arginine to proline conversion (40), we exclusively used SILAC labeling with lysine and 
digestion with endoproteinase Lys-C. Our data complements the recently published 
PeptideAtlas of the fission yeast proteome obtained using trypsin (19), and increases the 
coverage of the S. pombe proteome from 3,542 to a total of 4,068 proteins.  
 
In the replicate analyzed we were able to relatively quantify 80 % of all identified proteins in at 
least one cell cycle phase and 65 % of the proteins in all phases. Surprisingly, despite detecting 
many proteins for which the mRNA was shown to fluctuate during the cell cycle (50-52), the 
variations in protein abundance were low. Analysis of phosphoproteome dynamics showed a 
different picture: of 3,682 phosphorylation events, at least 30 % were fluctuating, confirming 
that considerable cell cycle regulation occurs through phosphorylation. We suspect that the 
mRNA fluctuations are not translated into proteome changes because we use a culture that is 
cycling at maximum speed. Slower progression through the cell cycle would provide the time 
needed to reach a new steady state of protein abundance based on the modified mRNA level. 
Possibly, phosphorylation is used for fast changes in the cell cycle, whereas changes in the 
proteome only occur on a slower time scale. Our data also suggest that most cell cycle-
dependent changes on the mRNA level are not essential for cell cycle progression. It should 
be noted that our synchronization strategy involved a temperature shift. This and sample 
processing may elicit stress responses, which could lead to proteome and phosphoproteome 
changes that are superimposed to the cell cycle changes. However, this does not affect our 
conclusion that there is surprisingly little protein fluctuation in these synchronized, fast cycling 
cells.  
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To complement the relative quantification we estimated copy numbers of 3,178 proteins using 
iBAQ (24). Proteins that fluctuate across the cell cycle have a low abundance and represent 
only 0.35 % of the total amount of protein in the cell (4th quartile). In contrast to the proteome, 
fluctuating phosphorylation events are present on proteins of the entire abundance range. We 
could also confirm that smaller proteins tend to be more abundant than larger proteins, as had 
previously been seen in budding and fission yeast (18, 19, 53) (Supplementary Figure 10).  
The use of SILAC-based relative quantification enabled us to address the stoichiometry of 
detected phosphorylation events. As expected, the overall phosphorylation level was peaking 
in mitosis, where it was about two-fold higher than in the other cell cycle phases. Our median 
occupancy of single sites in M phase (44 %) was significantly lower than reported in HeLa cells 
(~70 %) (4). The reasons could include biological (species-related) differences as well as 
experimental differences, since Nocodazole was used to arrest HeLa cells, whereas our cells 
progressed through mitosis unperturbed.  
 
It is important to point out that calculations of absolute levels depend on many different 
parameters such as cell counting, cell size measurement, iBAQ measurement, determination 
of UPS standard and protein concentration. As each of these parameters presents a source of 
error, only approximate absolute values can be determined. Nevertheless, our dataset shows 
good correlation with previously reported similar datasets and satisfactory internal control 
parameters, such as stoichiometry of known complex subunits. Hence, the data reported here 
will be a useful resource for classical and systems biologists alike.  
 
3.6 Contributions 
Silke Hauf and Boris Macek designed the experiments. Sabine Graf and André Koch 
performed cell culture, immunoblot analyses, microscopy, and phosphoproteome experiments. 
Karsten Krug performed bioinformatic analysis. Sasa Popic calculated phosphorylation site 
stoichiometry with my assistance. I performed MS measurements, proteome analysis, ATP 
quantification and data processing and prepared most of the figures. Silke Hauf, Boris Macek 
and I wrote the manuscript. My contribution to this manuscript was about 50%. 
 
  
74 
 
3.7 References 
1. Kastan, M. B., and Bartek, J. (2004) Cell-cycle checkpoints and cancer. Nature 432, 316-
323 
2. Malumbres, M., and Barbacid, M. (2009) Cell cycle, CDKs and cancer: a changing 
paradigm. Nat. Rev. Cancer 9, 153-166 
3. Lapenna, S., and Giordano, A. (2009) Cell cycle kinases as therapeutic targets for cancer. 
Nat. Rev. Drug Discov. 8, 547-566 
4. Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., Gnad, 
F., Cox, J., Jensen, T. S., Nigg, E. A., Brunak, S., and Mann, M. (2010) Quantitative 
Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During 
Mitosis. Sci. Signal. 3, ra3- 
5. Pagliuca, F. W., Collins, M. O., Lichawska, A., Zegerman, P., Choudhary, J. S., and Pines, 
J. (2011) Quantitative proteomics reveals the basis for the biochemical specificity of the 
cell-cycle machinery. Mol. Cell 43, 406-417 
6. Forsburg, S. L., and Nurse, P. (1991) Cell Cycle Regulation in the Yeasts Saccharomyces 
Cerevisiae and Schizosaccharomyces Pombe. Annu. Rev. Cell Biol. 7, 227-256 
7. Ghaemmaghami, S., Huh, W., Bower, K., Howson, R. W., Belle, A., Dephoure, N., O'Shea, 
E. K., and Weissman, J. S. (2003) Global analysis of protein expression in yeast. Nature 
425, 737-741 
8. Ross, P. L., Huang, Y. L. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., 
Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., 
Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein 
quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. 
Mol. Cell. Proteomics 3, 1154-1169 
9. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) 
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. 
Biotechnol. 17, 994-999 
10. Ho, Y., et al. (2002) Systematic identification of protein complexes in Saccharomyces 
cerevisiae by mass spectrometry. Nature 415, 180-183 
11. de Godoy, L. M. F., Olsen, J. V., Cox, J., Nielsen, M. L., Hubner, N. C., Froehlich, F., 
Walther, T. C., and Mann, M. (2008) Comprehensive mass-spectrometry-based proteome 
quantification of haploid versus diploid yeast. Nature 455, 1251-U1260 
12. Flory, M. R., Lee, H., Bonneau, R., Mallick, P., Serikawa, K., Morris, D. R., and Aebersold, 
R. (2006) Quantitative proteomic analysis of the budding yeast cell cycle using acid-
cleavable isotope-coded affinity tag reagents. Proteomics 6, 6146-6157 
13. Breitkreutz, A., Choi, H., Sharom, J. R., Boucher, L., Neduva, V., Larsen, B., Lin, Z. Y., 
Breitkreutz, B. J., Stark, C., Liu, G. M., Ahn, J., Dewar-Darch, D., Reguly, T., Tang, X. J., 
75 
 
Almeida, R., Qin, Z. S., Pawson, T., Gingras, A. C., Nesvizhskii, A. I., and Tyers, M. (2010) 
A Global Protein Kinase and Phosphatase Interaction Network in Yeast. Science 328, 
1043-1046 
14. Schmidt, M. W., Houseman, A., Ivanov, A. R., and Wolf, D. A. (2007) Comparative 
proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe. 
Mol. Syst. Biol. 3 
15. Matsuyama, A., Arai, R., Yashiroda, Y., Shirai, A., Kamata, A., Sekido, S., Kobayashi, Y., 
Hashimoto, A., Hamamoto, M., Hiraoka, Y., Horinouchi, S., and Yoshida, M. (2006) 
ORFeome cloning and global analysis of protein localization in the fission yeast 
Schizosaccharomyces pombe. Nat Biotech 24, 841-847 
16. Nurse, P. (1985) Cell cycle control genes in yeast. Trends in genetics : TIG 1, 51-55 
17. Koch, A., Krug, K., Pengelley, S., Macek, B., and Hauf, S. (2011) Mitotic Substrates of the 
Kinase Aurora with Roles in Chromatin Regulation Identified Through Quantitative 
Phosphoproteomics of Fission Yeast. Sci. Signal. 4, rs6 
18. Marguerat, S., Schmidt, A., Codlin, S., Chen, W., Aebersold, R., and Bähler, J. (2012) 
Quantitative Analysis of Fission Yeast Transcriptomes and Proteomes in Proliferating and 
Quiescent Cells. Cell 151, 671-683 
19. Gunaratne, J., Schmidt, A., Quandt, A., Neo, S. P., Sarac, O. S., Gracia, T., Loguercio, S., 
Ahrne, E., Li Hai Xia, R., Tan, K. H., Loessner, C., Bahler, J., Beyer, A., Blackstock, W., 
and Aebersold, R. (2013) Extensive Mass Spectrometry-Based Analysis of the Fission 
Yeast Proteome: The S. pombe PeptideAtlas. Mol. Cell. Proteomics 
20. Wilson-Grady, J. T., Villen, J., and Gygi, S. P. (2008) Phosphoproteome analysis of fission 
yeast. J. Proteome Res. 7, 1088-1097 
21. Beltrao, P., Trinidad, J. C., Fiedler, D., Roguev, A., Lim, W. A., Shokat, K. M., Burlingame, 
A. L., and Krogan, N. J. (2009) Evolution of phosphoregulation: comparison of 
phosphorylation patterns across yeast species. PLoS Biol. 7, e1000134 
22. Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., and Mann, M. (2014) Minimal, encapsulated 
proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat 
Meth 11, 319-324 
23. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R., and Mann, M. (2010) Super-SILAC 
mix for quantitative proteomics of human tumor tissue. Nat Meth 7, 383-385 
24. Schwanhausser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., and 
Selbach, M. (2011) Global quantification of mammalian gene expression control. Nature 
473, 337-342 
25. Moreno, S., Hayles, J., and Nurse, P. (1989) Regulation of p34cdc2 protein kinase during 
mitosis. Cell 58, 361-372 
76 
 
26. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R., and Mann, M. (2010) Super-SILAC 
mix for quantitative proteomics of human tumor tissue. Nat. Methods 7, 383-385 
27. Heinrich, S., Geissen, E. M., Kamenz, J., Trautmann, S., Widmer, C., Drewe, P., Knop, M., 
Radde, N., Hasenauer, J., and Hauf, S. (2013) Determinants of robustness in spindle 
assembly checkpoint signalling. Nat. Cell Biol. 15, 1328-1339 
28. Franz-Wachtel, M., Eisler, S. A., Krug, K., Wahl, S., Carpy, A., Nordheim, A., Pfizenmaier, 
K., Hausser, A., and Macek, B. (2012) Global Detection of Protein Kinase D-dependent 
Phosphorylation Events in Nocodazole-treated Human Cells. Mol. Cell. Proteomics 11, 
160-170 
29. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. 
V., and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates 
major cellular functions. Science 325, 834-840 
30. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micro-purification, 
enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. 
Nature protocols 2, 1896-1906 
31. Olsen, J., and Macek, B. (2009) High Accuracy Mass Spectrometry in Large-Scale Analysis 
of Protein Phosphorylation. In: Lipton, M., and Paša-Tolic, L., eds. Mass Spectrometry of 
Proteins and Peptides, pp. 131-142, Humana Press 
32. Hubner, N. C., Ren, S., and Mann, M. (2008) Peptide separation with immobilized pI strips 
is an attractive alternative to in-gel protein digestion for proteome analysis. Proteomics 8, 
4862-4872 
33. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micro-purification, 
enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. 
Protocols 2, 1896-1906 
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3.8 Supporting information 
 
Supplementary tables S1 – S10 and Supplementary Data Files I and II are contained in the 
CD attached.  
 
 
 
Supplementary Figure 1: Cell synchronization. (A) Fluorescence microscopy for the super-SILAC standard and 
the experimental samples using Plo1 kinase tagged with mCherry, proliferating cell nuclear antigen 
Pcn1 tagged with EGFP and DAPI staining to label DNA. (B) Synchronicity for all analyzed cell cycle 
phases based on manual counting. 
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Supplementary Figure 2: Comparison of super-SILAC standards. Plot showing the correlation of the 
intensity of proteins identified in the super-SILAC standard from the G1G2 experiment against 
the intensity of proteins from the MS experiment in the log10 scale for both replicates. 
 
 
Supplementary Figure 3: Comparison of the SILAC ratios and of phosphopeptide ratios before and after 
normalization for both replicates. The ratios of both replicates for the studied cell cycle phases 
were compared for (A) protein groups and (B) phosphorylation events. The Pearson’s 
correlation coefficient for proteome measurements is low because most protein groups have 
low variance; nevertheless high reproducibility was observed. The effect of protein abundance 
on phosphorylation ratios was compared by plotting the phosphorylation events ratios before 
(x-axis) and after (y-axis) normalization by protein abundance for both (C) replicate 1 and (D) 
replicate 2.  
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Supplementary Figure 4: Correlation of immunoblots with MS data. Immunoblots of tubulin, Uds1-GFP, Cdc13 
(cyclin B), S10-phosphorylation on histone H3, and their correlation with MS data in both replicates. 
Cdc2 servers as loading control. The tested proteins showed good agreement to the MS data, 
supporting the high quality of quantification across cell cycle phases.  
 
 
 
Supplementary Figure 5: Correlation of fluorescence microscopy with MS data. Fluorescence microscopy of 
Uds1-GFP, Plo1-mCherry (which marks mitotic cells) and the DNA-stain DAPI across the studied cell 
cycle phases. In accordance with immunoblot and MS data (Supplementary Fig. 4), Uds1 (up-regulated 
during septation) increased in abundance from G2 to S, where it marks the region of septation. These 
data are in agreement with Bicho et al. 
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Supplementary Figure 6: Functional enrichment analysis. Functional enrichment analysis of the (A) proteome 
data, (B) phosphorylation data and (C) canonical kinase motifs performed separately for the different 
classes of fluctuating proteins. The canonical kinase motifs were extracted from the Human Protein 
Reference Database. Functional enrichment analysis of (D) proteins and (E) phosphorylation sites in 
the cell cycle phase-specific clusters. 
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Supplementary Figure 7: Absolute quantification validation. (A) The linear regression used for absolute 
quantification was obtained by plotting the MS signals against known concentrations of the UPS2 
protein standard. (B) Protein abundance in this study against abundance of selected proteins 
measured by fluorescence correlation spectroscopy in a study by Heinrich et al. (C) Comparison of 
protein abundance obtained in this study to values reported in Marguerat et al. The MA-plot in the left 
panel depicts the average (x-axis) plotted against the difference (y-axis) in log2-scale between 
measured protein abundance. The scatterplot in the right panel shows the correlation of protein 
abundance (log10-scale) together with a trendline obtained by linear regression. Small blue lines at the 
axes represent the abundance of proteins exclusively detected in one of the studies. (D) Comparison 
to Gunaratne et al. (E) Comparison to Kulak et al. (F) Comparison to Wu et al. 
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Supplementary Figure 8: Protein copy number distribution. Histograms of protein abundance in the studied 
cell cycle phases.  
 
 
Supplementary Figure 9: Protein bound phosphate. (A) Cumulative diagram of absolute protein bound 
phosphate groups for the separate cell cycle phases with bootstrap confidence intervals. (B) Median 
occupancy values resulting from 10,000 bootstrap iterations. The error bars correspond to a 95% 
bootstrap confidence interval used to calculate the lower and upper limits as shown in (A). 
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Supplementary Figure 10: Absolute quantification. (A) Box plots of the protein copy number distribution and (B) 
absolute protein bound phosphate groups in the quartiles (bins) of standard deviations, the number in 
brackets is the contribution of each quartile in percent to the absolute amount of protein in the cell. (C) 
Box plot diagram of the distribution of protein abundance for all protein and phosphorylated proteins. 
(D) Dependence of sequence length and protein abundance. 
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4. Nic1 inactivation enables SILAC labeling with 13C615N4-Arginine in S. pombe 
(Manuscript III) 
 
Alejandro Carpy, Avinash Patel, Tay Ye Dee, Iain Hagan, Boris Macek 
 
This chapter is under revision: 
Carpy, A., Patel, A., Dee T.Y., Hagan, I., Macek, B. (2014) Nic1 inactivation enables SILAC 
labeling with 13C615N4-Arginine in S. pombe. Under revision in Molecular & cellular 
proteomics : MCP 
 
4.1 Abstract 
The inability to use 13C615N4-arginine in SILAC-based proteomics limits the exploitation of 
SILAC technology in fission yeast. The guanidinium group of 13C615N4-arginine is catabolized 
to 15N1-ammonia that is used as a precursor for general amino acid biosynthesis. We show 
that disruption of Ni2+-dependent urease activity, through deletion of the sole Ni2+ transporter 
Nic1 in ammonium supplemented medium blocks this re-cycling to enable 13C615N4-arginine 
labeling for SILAC strategies in S. pombe.  
 
4.2 Introduction 
Stable Isotope Labeling by Amino acids in Cell culture (SILAC) is one of the most widely used 
methods in quantitative proteomics (1). It involves in vivo metabolic labeling of cell cultures (or 
small organisms) with different versions of stable isotope-labeled essential amino acids (2). To 
maximize the number of peptides that can be quantified after proteome digestion with trypsin, 
proteins are usually differentially labeled with different forms of lysine and arginine (3): L- lysine 
(K0) and L-arginine (R0), 2H4-lysine (K4) and 13C6-arginine (R6), or 13C6-15N2–lysine (K8) and 
13C6-15N4-arginine (R10). In yeast cells, where lysine and arginine are not essential, the use of 
auxotrophic mutants allows complete labeling of all tryptic peptides (4, 5). SILAC has been 
used in quantitative proteomics in several yeast species, but most widely in Saccharomyces 
cerevisiae (6) (budding yeast) and Schizosaccharomyces pombe (fission yeast). S. pombe is 
extensively exploited to study cell cycle control (7), heterochromatin (8) and differentiation (9) 
and is increasingly the subject of large-scale quantitative proteomics studies (10, 11). One of 
the major challenges faced when applying SILAC to fission yeast is metabolic conversion of 
arginine to other amino acids such as proline, glutamine and lysine (5). This results in the 
partial labeling of the respective amino acids and produces a mass spectrum with a complex 
isotope cluster that makes the downstream analysis challenging and error-prone. However, 
inactivation of the “arginine conversion pathway” by removal of the orthinine transferase, Car2, 
overcomes this problem to enable the use of arginine labeling in SILAC-based experiments 
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(5). Although the use of car2. has facilitated the application of SILAC technology in fission 
yeast, the choice of amino acids that can be exploited remains limited. Only one form of heavy 
arginine (R6) can be used (12) alongside three forms of heavy lysine (K4, K6 and K8) (5, 13). 
Surprisingly, we could not find any instance of reported use of arginine (R10) in fission yeast 
in the literature although this is a common reagent for labeling other cell types (1). 
 
4.3 Materials and methods 
Yeast strains  
Strain No. Genotype Source 
IH 5224 h+ pku70::kan ura4.d18 leu1.32 ade6.704 Lab Stock 
IH 6113 pku80::ura+ ura4.d18 leu1.32 Lab Stock 
IH 8988  h+ car2::NatMX6 This study 
IH 8987  h- car2::NatMX6 This study 
IH 6297  h- arg3.D4 Lab Stock 
IH 1540  h+ lys1.131 Lab Stock 
IH 9091  h- car2::NatMX6 lys1.131 arg3.D4 ura4.d18 leu1.32 This study 
IH 9092  h+ car2::NatMX6 lys1.131 arg3.D4 ura4.d18 leu1.32 This study 
IH 9281 
plo1.ts41:ura4+ cut7.24 lys1.131 arg3.D4 car2::NatMX6 ura4.d18 
leu1.32 
This study 
IH 11849 h- nic1::KanMX6 car2::NatMX6 lys1.131 arg3.D4  This study 
 
Standard yeast culture 
Strains used in this used study are listed above. Cell culture and maintenance were according 
to Moreno et al. (14). The amino acid supplements were uracil, adenine, leucine and histidine 
at a concentration of 200g/mL. Yeast strains were streaked onto YES plates (Solid Yeast 
Extract agar with supplements) from the frozen glycerol stocks at -80 °C, and grown at the 
permissive temperature (25 °C) until single colonies formed. One single colony was used to 
start liquid cultures. For all the physiological experiments, asynchronous cultures of cells were 
grown in variants of Edinburgh minimal media 2 (EMM2), with appropriate supplements from 
log phase starter cultures (1x106 – 5 x106 cells/mL). In EMMG, the 5g/l ammonium chloride of 
EMM2 is replaced with 5g/l monosodium glutamate (15). In EMMGn, EMMG is supplemented 
with 12 mM NH4Cl.  
 
S. pombe transformation using lithium acetate 
Cultures that had been grown in YES (nutrient rich) to mid-log phase (4x106 - 8x106 cells/mL) 
were pelleted by centrifugation at 3400 g for 2 min, washed once in water followed by re-
suspension in appropriate volume of lithium acetate (0.1 M, pH 4.9) to achieve 2x108 cells/ml. 
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After 1 hour at 25 °C 10-15 μg of DNA was added to 100 l of competent cells alongside 2.9 
volumes of PEG 4,000 (50% (w/v) in 0.1 M, pH 4.9 lithium acetate). After 1 hour at 25 °C and 
15 minutes at 42 °C cells were washed once in water and plated onto selective minimal media. 
 
SILAC-Labeling 
L-lysine:2HCl (4,4,5,5-D4, 96-98%, Cambridge Isotopes, cat no. DLM-2640-0.5) and L-
arginine:HCl (U-13C6, 99%, Cambridge Isotopes, cat no. CLM-2265-H-0.5) were used as 
medium isotopic labels; L-lysine:2HCl (U-13C6, 99%; U-15N2, 99%, Cambridge Isotopes, cat 
no. CNLM-291-H-0.25) and L-arginine:HCl (U-13C6, 99%; U-15N4, 99%, Cambridge Isotopes, 
cat no. CNLM-539-H-0.5) were used as heavy isotopic labels.  
 
Cell Culture 
EMMG media is equivalent to EMM2(16) except that 5 g/l ammonium chloride is replaced with 
5 g/l mono-sodium glutamate (15). EMM2 media was also prepared with a range of ammonium 
chloride concentrations up to 96 mM. EMMGn is EMMG containing 12 mM NH4Cl. To label the 
cells with heavy or medium isotopic labels for Arginine (R) and Lysine (K), starter cultures were 
prepared by inoculation into EMMG/EMMGn supplemented with 37.5 g/mL each of light and 
medium/heavy isotopic versions of arginine and lysine. After inoculation from log phase starter 
cultures, main cultures were grown in EMMG/EMMGn supplemented with 75 g/mL of heavy 
isotopic labeled R and K for at least 10 generations before sampling to ensure the maximum 
labeling of the proteome. Care was taken that the culture never exceeded the mid-log phase 
(1 – 5 x 106) at which they were ultimately harvested. For direct comparisons with the EMM2 
experiments of Bicho et al. (5) it was necessary to make starter cultures in YES media before 
inoculation into EMM2 as we were repeatedly unable to get growth in main cultures of either 
the SILAC strain when both the starter and main culture were made in minimal selective 
medium.  
 
SILAC strain 
The 100 bp primer pair (CAR2_FORW, AAGTCAGATTATCAAAGGAGTTAAGAGATTATTGT 
GTAATCTTGAATCAGTTTTCTTTAGGTCTTAGTAAATTCTTCATTCGGATCCCCGGGTTAA
TTAA; CAR2_REV, TGTAGTCATCGAACCCTTAACATTAGAAGGGAGGTAAGTAAGAATGA 
ATCGTCTAGTTTTTTTGTTTAAAGCATTGTTTTGAATTCGAGCTCGTTTAAAC) were 
designed such that the first 80 nucleotides were homologous to the sequences flanking the 
car2+ gene and the last 20 nucleotides were homologous to the pYM14 template plasmid with 
the natMX6 marker (pFA6natMX6)(17). The PCR product was transformed into the strain 5224 
(pku70::kan ura4.d18 leu1.32 ade6.704) and colonies that were resistant to 
Nourseothricin/ClonNat (Werner BioAgents, 96736-11-7) were selected. After PCR analysis 
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confirmed the desired integration event two rounds of back- crossing to wt removed the 
pku70::kan before arginine and lysine auxotrophic markers arg3.d4 and lys1.131 were 
introduced to generate the SILAC strain (car2::natMX6 arg3.d4 lys1-131; IH 9091 and 9092). 
 
SILACn strain 
The 100 bp primer pair (NIC1_FORW, AAAATTGTTATTATTATTGGAATCCT 
AAGTGGATACAGGTTTATGTGAACGCAATCTATTCAAATTACGCGTTTATTTGTTTAATTA
AGGCGCGCCAGAT; NIC1_REV, ACGACTGGGAATTTCTGTTTCCTTTTTTTTTCTTCAGTA 
TTCTCGATTTGTTCTCTTAACCTGTTGCTTGGGTTAAAAGTGTTTAAACTGGATGGCGGC
G) were designed such that the first 80 nucleotides were homologous to the sequences 
flanking the nic1+ gene and the last 20 nucleotides were homologous to the pYM14 template 
plasmid with the natMX6 marker (pFA6natMX6) (5, 17, 18). The PCR product was transformed 
into the strain IH6113 (pku80::ura+ ura4.d18 leu1.32) and colonies that were resistant to 
Geneticin (MP Biomedicals, 158782) were selected. These were further confirmed for the 
integration at the desired locus by two rounds of back- crossing to wt before crossing into the 
SILAC base strain generated the SILACn base strain (h- nic1::KanMX6 car2::NatMX6 lys1.131 
arg3.D4; IH 11849). 
 
Cell extracts for proteomics experiments 
5 x107 cells in log phase of growth were harvested at 4000 rpm for 2 minutes in screw cap 1.5 
mL microfuge tubes. Cell pellets were washed once in ice-cold STOP buffer (10 mM EDTA, 
50 mM NaF, 150 mM NaCl, 1 mM NaN3) and then flash frozen in liquid nitrogen and kept in -
80oC. Proteins were extracted by breaking the cells with 200 µL acid washed glass beads in 
the presence of 200 μL of denaturation buffer (6M Urea, 2M Thio-urea in 10mM Tris buffer pH 
8.0) in a ribolyser (Fast prep FP120-BIO101, ThermoSavant) used for 30 sec at 6.5 rpm. Then 
200 μL of denaturation buffer was added to the glass beads and the tubes were incubated on 
a rotating rocker at RT for 30 mins. In the bottom of each tube a hole was made and each tube 
was placed on the top of the empty 1.5 mL microfuge tube and spun at 4800 rpm for 2 min at 
RT. The insoluble debris was separated by centrifugation at 13,000 rpm for 10 min at RT. The 
supernatant was collected in a fresh 1.5 mL microfuge tube and comprised the sample that 
would be processed for LC-MS/MS. Protein concentration was measured using Bradford.  
 
In-solution protein alkylation and digestion 
Reduction buffer [1 M dithiothreitol (DTT) in 50 mM ammonium bicarbonate (ABC)] was added 
to the sample to a final concentration of 1mM DTT; and incubated at room temperature (RT) 
for 1 hour. After reduction, alkylation buffer [550mM iodoacetamide (IAA) in 50 mM ABC] was 
added to the sample to a final concentration of 5.5 mM IAA and incubated at RT for 1 hour in 
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the dark. Sample was then digested with endopeptidase LysC (Waco chemicals, 1:100 
enzyme:protein) at RT for 3 hours. After digestion with LysC at high urea concentration, the 
sample was diluted to a final concentration of 1.2 M urea / 0.4 M thiourea with MiliQ water and 
digested with trypsin (Promega, 1:100 enzyme:protein) at RT overnight. The samples were 
acidified to inactivate trypsin by adding 1% TFA and desalted using C18 StageTips (19). 
 
MS analysis 
Desalted peptide fractions were separated using a nano-LC (Proxeon Biosystems) coupled to 
either an Orbitrap Elite or a LTQ Orbitrap XL (Thermo Fisher Scientific) mass spectrometer 
(MS). Peptides were separated on a 15 cm PicoTip fused silica emitter with a 75 µm ID (New 
Objective) packed with ReproSil-Pur C18-AQ 3 µm resin (Dr. Maisch GmbH) in-house. 
Peptides were loaded in the column with Buffer A (0.5% acetic acid) at 700 nL/min using a 
maximum pressure of 280 Bar. Peptides were then eluted using a 57 or 87 min segmented 
gradient of 5-50% Buffer B (80% ACN in 0.5% acetic acid) at a flow rate of 200 nL/min. The 
mass spectrometers were operated in the positive ion mode. Spectra were recorded with data-
dependent mode using a dynamic exclusion of 90 sec (LTQ Orbitrap XL) or 60 sec (Orbitrap 
Elite). Resolution was set at 60,000 (LTQ Orbitrap XL) or 120,000 (Orbitrap Elite) with an 
accumulation target value of 1E6 charges. For peptide analysis the 10 (LTQ Orbitrap XL) or 
20 (Orbitrap Elite) most intense peaks were selected from the survey scan (300-2,000 
Thompson) and fragmented with collision induced dissociation at a target value of 5,000 
charges and recorded in the linear ion trap. 
 
MS data processing 
The MS data were analyzed with the MaxQuant Software Package version 1.3.0.5(20) and 
searched using the Andromeda peptide search engine (21). The MS/MS spectra were 
searched against a database containing the proteome sequence of the S. pombe which was 
downloaded from http://www.pombase.org (03.01.2013). The database contained 5,145 
entries from the S. pombe proteome, 248 frequently observed contaminants as well as the 
reverse version of all sequences. Mass tolerance was set to 6 ppm at the MS and 0.5 Da at 
the MS/MS level. A minimal length of seven amino acids and full tryptic enzyme specificity 
were required. Two enzyme missed cleavages were allowed. Oxidation of methionine and 
protein N-terminal acetylation were defined as variable modifications and 
carbamidomethylation of cysteins was used as fixed modification. False discovery rate was set 
to 1% on the peptide and protein level. 
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Immunofluoresence for microtubules and spindle pole body 
Immunofluorescence was performed as described by Hagan and Yanagida (22). The Sad1 
(spindle pole body component) and 1:80 TAT1 (Trypanosome Alfa Tubulin) (23) antibodies 
were diluted 1:25 and 1:80 respectively and used as primary antibodies. FITC anti-mouse 
antibody (Sigma Aldrich) for TAT1 and Cy3 anti-rabbit antibody (Sigma Aldrich) for Sad1 in 
PEMBAL were used as secondary antibodies at a dilution of 1:100 and 1:2500 respectively.  
 
4.4 Results and discussion 
To assess the feasibility of using arginine (R10) for quantitative proteomics of fission yeast, we 
performed SILAC labeling of S. pombe cells as described by Bicho et al (5). We used arg3.d4 
lys3.131 car2::natMX6 background and refer to this genotype as “SILAC” in the following text. 
Consistent with previous observations (5), the SILAC strain grows poorly in the EMM2 medium 
that uses ammonium as a nitrogen source (Figure 1a). Ammonium ions inhibit one of two 
arginine uptake pathways, to severely compromise the growth of arginine auxotrophs such as 
 
 
Figure 1. Metabolic characterization of S. pombe. (a) Growth curve of the SILAC strain in EMMG and 
EMMS media supplemented with different concentrations of ammonium chloride. (b) Monopolar 
spindle scoring, plo1.ts41 cut7.24 SILAC cells were grown in the EMMG and EMMS media at 25oC 
to a cell density of 1 x 106. Cells were shifted to 37oC and immunostained to score for monopolar 
strains in EMMG media. (d) Metabolism of arginine in S. pombe. For full description of genotype of 
mutant strains see methods section. 
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the SILAC strain (24). Substitution of ammonium for monosodium glutamate in the medium 
EMMG enables both arginine import pathways to be used. Our experimental approach 
therefore deviated from that of Bicho by growth in EMMG rather than the reduced ammonium 
EMM2 used in their study. Monitoring the formation of monopolar spindles in a plo1.ts41 
cut7.24 double mutant (25, 26) established that this switch of nitrogen source did not appear  
to alter phenotypic expression in the SILAC mutant background (Figure 1b). Furthermore, the  
SILAC strain growth in EMMG media is comparable to that of the WT (Figure 1c).  
 
While performing a standard triple SILAC experiment using “light” (K0R0), “medium” (K4R6) 
and “heavy” (K8R10) amino acids in EMMG we noticed that almost all heavy (K8R10)-labeled 
peptides had complex isotope clusters that impede the identification of heavy peptides and 
proteins. Importantly, this complex isotope clusters were present in both arginine- and lysine-
 
 
 
Figure 2.  Assessment of arginine conversion using MS. Isotopic distribution of peptides from a triple-
SILAC experiment for an arginine and a lysine containing peptide using the SILAC strain (top) and 
an arginine and a lysine containing peptide using the SILACn strain (bottom). (b) Peptide sequences 
identified in individual experiments using different isotopic versions of lysine and arginine. The lines 
on the top indicate the media used and the colored background indicates the strain used.  
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containing peptides (Figure 2a), pointing to a global conversion of the stable isotope label 
introduced by heavy arginine and/or lysine. To pinpoint the heavy amino acid responsible for 
the conversion, we measured samples labeled with a single heavy label (R0K8 or R10K0). 
Only the sample containing heavy arginine (R10K0) presented the complex isotope cluster 
observed before and the identification rate was reduced (Figure 2b; Summary of the proteins 
identified in each experiment is presented in the Supplementary Tables 1 - 12).  
 
We reasoned that this extensive mislabeling of multiple amino acids probably arose from 
catabolism of heavy arginine (R10) to heavy urea. Catalysis by Car1 and Aru1 would convert 
the guanidine group from arginine into urea which could be further catabolized by ureases into 
ammonia (Figure 1d) (5). The 15N1-ammonia derived from 15N2-urea would then be 
incorporated into multiple amino acids, that each contains different numbers of 15N atoms to 
alter the isotope distributions of all peptides. Unlike the medium-heavy 13C6-arginine (R6), only 
heavy 15N413C6-arginine (R10) has isotopically labeled nitrogen and so only samples labeled 
with arginine (R10) are vulnerable to this urease catabolism problem. Consistently, in 
measurements of samples containing only medium-heavy amino acids arginine (R6) and lysine 
(K4), no such conversion was observed (Figure 2b).  
 
Ureases require Ni2+ as the major cofactor for their catalytic activity. S. pombe encodes one 
characterized urease (Ure1) (27) alongside several other proteins that are predicted to have a 
urease activity. Nic1 is the sole plasma membrane Ni2+ transporter and supports urease activity 
of fission yeast (28). We therefore reasoned based on observations from Eitinger et al. (28), 
that global reduction of the urease activity by abolition of Nic1 activity would reduce amino acid 
mislabeling when the SILAC strain was grown on heavy arginine (R10). We therefore deleted 
nic1+ in the SILAC strain to generate “SILACn” before repeating the SILAC labeling as 
described above. nic1. introduction resulted in an increase in the identification of arginine 
(R10)-labeled peptides, suggesting that urease-dependent arginine catabolism was indeed a 
key factor in arginine (R10) mislabeling (Supplementary Figure 1). However, the quantity of 
peptides identified in samples labelled with heavy amino acids was still lower than in samples 
containing light amino acids and the isotopic distribution of peptides was unusual, suggesting 
a partial incorporation of 15N atoms. The incomplete suppression suggested that residual 
traces of Ni2+ persist in nic1. cells or that the urea is catabolized to ammonium ions by Ni2+ 
independent urease/pathways.  
 
The increased identification rate of (R10) labeled peptides in the SILACn background indicated 
that, although 15N-ammonium has not been completely eliminated by removal of Nic1, its levels 
were severely reduced. We therefore asked whether we could outcompete the exploitation of 
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these low levels of 15N-ammonium ions in amino acid anabolic pathways by supplementing the 
EMMG growth medium with unlabeled 14N-ammonium ions that are tolerated by SILAC 
strains(5). The SILACn strain grew in EMMG media that contained 12mM NH4Cl (EMMGn) 
alongside stable isotope-labelled amino acids with a doubling rate of 7 hours. For reasons that 
are not clear, the original SILAC strain (nic1+) grew very poorly in EMMGn (data not shown). 
Importantly, however, the regular isotope pattern of the heavy-labeled peaks established that 
growth of SILACn cells in EMMGn successfully resolved the mislabeling problem (Compare 
figure 2a top spectra with bottom spectra). This improved detection rate enabled us to 
identify comparable numbers of heavy labeled peptides as detected in cells labeled with light 
or medium amino acids (Figure 2b).  
 
We conclude that removal of Nic1 from cells grown in EMMGn finally renders fission yeast fully 
compatible with SILAC labeling to greatly expand the options for interrogation of the S. pombe 
proteome. The ability to routinely conduct triple SILAC analysis in this genetically malleable 
model organism will rapidly advance our quantitative understanding of many core principles of 
molecular cell biology.  
 
4.5 Contributions 
Avinash Patel and I exposed the mislabeling problem, while realizing label incorporation 
checks. With the help of Boris Macek and Iain Hagan, we reasoned the pathway responsible 
for the mislabeling and designed experiments. Avinash Patel and Tay Ye Dee transformed and 
grew the cells. I realized the protein extraction, LC-MS/MS measurements and analyzed the 
data. Figures were also prepared by myself. I wrote the manuscript with Boris Macek and Iain 
Hagan with support from all the authors. My contribution to this manuscript was about 50%. 
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4.7 Supporting information 
 
Supplementary tables are contained in the CD attached.  
 
 
Supplementary figure 1. SILACn strain grown in EMMG media. (a) Spectra from the isotopic distributions for an 
arginine containing peptide labelled with light, medium or heavy amino acids. (b) Peptide sequences 
and protein groups identified.  
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5. Conclusions 
In this thesis I developed, optimized and applied several methods in order to characterize 
fission yeast using MS-based quantitative proteomics. From this studies I can conclude the 
following: 
 
1. Optimization of quantitative proteomics and phosphoproteomics methods 
a. The use of DHB can be efficiently avoided by using high concentrations of TFA and 
acetonitrile (ACN). 
b. The sequential enrichment of fractions containing high amount of phosphopeptides 
leads to higher number of phosphosite identifications.  
c. This approach is universal and can be applied to several organisms.  
 
2. Study of the absolute proteome and phosphoproteome dynamics during the cell cycle of 
the fission yeast 
a. The approach used is adequate to characterize the fission yeast proteome with a 
high coverage. The 3,753 proteins identified in our study represent 74% of the 
predicted fission yeast proteins, making it one of the most comprehensive published 
protein dataset of this organism to date. Furthermore, this approach is adequate to 
characterize fission yeast since we were able to relatively quantify 80% of all 
identified proteins in at least one cell cycle phase and 65% of the proteins in all 
phases. 
b. Cell cycle regulation occur mainly via phosphorylation. Despite detecting many 
proteins for which the mRNA was shown to fluctuate during the cell cycle, the 
variations in protein abundance were low. At the phosphorylation level from 3,682 
phosphorylation events, at least 30% were fluctuating. Our data also suggest that 
most cell cycle-dependent changes on the mRNA level are not essential for cell 
cycle progression. 
c. iBAQ can be used to absolute quantify fission yeast proteome. We estimated copy 
numbers of 3,178 proteins. Proteins that fluctuate across the cell cycle have a low 
abundance and represent only 0.35% of the total amount of protein in the cell (4th 
quartile) while fluctuating phosphorylation events are present on proteins of the 
entire abundance range. 
d. The use of SILAC-based relative quantification enabled us to address the 
stoichiometry of detected phosphorylation sites.  
e. In combination with absolute quantification it was possible to calculate the ATP 
dynamics during the cell cycle. 50 amol of ATP is required for protein STY 
phosphorylation during the G2/M transition. This corresponds to 23% of the 
99 
 
average amount of ATP in the cell. This approach can also be applied to other 
PTMs.  
 
3. Solving the “heavy labelling” problem in fission yeast  
a. The removal of Nic1 from cells grown in EMMGn renders fission yeast fully 
compatible with SILAC labeling and greatly expands the options for interrogation of 
the S. pombe proteome. The ability to conduct triple SILAC analysis will allow 
understanding of many core principles of molecular cell biology. 
b. This study may point the way towards solving of arginine-related labeling problems 
in SILAC experiments in other species. 
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